Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	ATP9B ABCA10 KIF15 STARD9 ATP6V1C2 PMS2P5 DDX31 DNAH10 DDX60 SMCHD1 ABCB5 UBA2 RFC3 MCM9 MACF1 ATP2B3 SNRNP200 DNAH11 CDK7	1.06e-05	614	196	19	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	ATP9B ABCA10 KIF15 PMS2P5 DDX31 DNAH10 DDX60 SMCHD1 ABCB5 RFC3 MCM9 MACF1 ATP2B3 SNRNP200 DNAH11	3.20e-05	441	196	15	GO:0016887
GeneOntologyBiologicalProcess	stress-activated protein kinase signaling cascade	AKR1B1 MAPK14 MAP3K13 MAPK3 MAPK11 MAP2K3 MAP2K6	3.98e-06	69	195	7	GO:0031098
HumanPheno	Aplasia/Hypoplasia of the tragus	GLI2 SF3B2 SMCHD1 NUP188	3.58e-06	8	79	4	HP:0009913
Domain	GF_recep_IV	PCSK5 ERBB2 ERBB4 EGFR	1.77e-07	6	197	4	PF14843
Domain	GF_recep_IV	PCSK5 ERBB2 ERBB4 EGFR	1.77e-07	6	197	4	IPR032778
Domain	Tyr_kinase_EGF/ERB/XmrK_rcpt	ERBB2 ERBB4 EGFR	4.59e-06	4	197	3	IPR016245
Domain	Furin_repeat	PCSK5 ERBB2 ERBB4 EGFR	3.27e-05	18	197	4	IPR006212
Domain	FU	PCSK5 ERBB2 ERBB4 EGFR	3.27e-05	18	197	4	SM00261
Domain	Recep_L_domain	ERBB2 ERBB4 EGFR	3.92e-05	7	197	3	PF01030
Domain	Furin-like	ERBB2 ERBB4 EGFR	3.92e-05	7	197	3	PF00757
Domain	Rcpt_L-dom	ERBB2 ERBB4 EGFR	3.92e-05	7	197	3	IPR000494
Domain	Furin-like_Cys-rich_dom	ERBB2 ERBB4 EGFR	3.92e-05	7	197	3	IPR006211
Domain	-	ERBB2 ERBB4 EGFR	3.92e-05	7	197	3	3.80.20.20
Domain	Kinase-like_dom	ERBB2 ERBB4 RAPH1 TRPM7 BMPR1A BMPR1B DMD MAPK14 EGFR MACF1 MAP3K13 MAPK3 MAPK11 MAP2K3 MAP2K6 CDK7	2.12e-04	542	197	16	IPR011009
Domain	MAPK	MAPK14 MAPK3 MAPK11	2.37e-04	12	197	3	PS01351
Domain	MAP_kinase_CS	MAPK14 MAPK3 MAPK11	2.37e-04	12	197	3	IPR003527
Domain	VDCC_L_bsu	CACNB1 CACNB4	6.55e-04	4	197	2	IPR000584
Domain	LRRC37AB_C	LRRC37A2 LRRC37A	6.55e-04	4	197	2	IPR029423
Domain	LRRC37AB_C	LRRC37A2 LRRC37A	6.55e-04	4	197	2	PF14914
Domain	MAPK_p38	MAPK14 MAPK11	6.55e-04	4	197	2	IPR008352
Domain	LRRC37_N	LRRC37A2 LRRC37A	6.55e-04	4	197	2	IPR032754
Domain	VGCC_beta4Aa_N	CACNB1 CACNB4	6.55e-04	4	197	2	PF12052
Domain	LRRC37	LRRC37A2 LRRC37A	6.55e-04	4	197	2	PF15779
Domain	KCL_cotranspt	SLC12A6 SLC12A7	6.55e-04	4	197	2	IPR000076
Domain	LRRC37A/B-like	LRRC37A2 LRRC37A	6.55e-04	4	197	2	IPR015753
Domain	GDS_CDC24_CS	ABR ARHGEF16 FARP2 ARHGEF1	7.40e-04	39	197	4	IPR001331
Domain	AAA	ABCA10 DNAH10 ABCB5 RFC3 MCM9 SNRNP200 DNAH11	8.50e-04	144	197	7	SM00382
Domain	AAA+_ATPase	ABCA10 DNAH10 ABCB5 RFC3 MCM9 SNRNP200 DNAH11	8.50e-04	144	197	7	IPR003593
Pathway	KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	5.18e-06	26	141	5	M47565
Pathway	WP_CARDIAC_HYPERTROPHIC_RESPONSE	HDAC7 MAPK14 MAPK3 MAP2K3 MAP2K6 CDK7	1.74e-05	55	141	6	M39685
Pathway	KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY	MAPK14 MAPK3 MAPK11	1.92e-05	6	141	3	M47766
Pathway	BIOCARTA_HCMV_PATHWAY	MAPK14 MAPK3 MAP2K3 MAP2K6	2.06e-05	17	141	4	M8353
Pathway	BIOCARTA_HCMV_PATHWAY	MAPK14 MAPK3 MAP2K3 MAP2K6	2.06e-05	17	141	4	MM1408
Pathway	WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	2.74e-05	36	141	5	M39908
Pathway	REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	3.14e-05	37	141	5	MM14899
Pathway	WP_MAPK_SIGNALING	PDGFA CACNA1F CACNB1 CACNB4 MAPK14 EGFR MAP3K13 MAPK3 MAPK11 MAP2K3 MAP2K6	3.65e-05	246	141	11	M39597
Pathway	BIOCARTA_NTHI_PATHWAY	MAPK14 MAPK11 MAP2K3 MAP2K6	6.10e-05	22	141	4	MM1443
Pathway	PID_CXCR3_PATHWAY	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	6.61e-05	43	141	5	M222
Pathway	KEGG_GNRH_SIGNALING_PATHWAY	CACNA1F MAPK14 EGFR MAPK3 MAPK11 MAP2K3 MAP2K6	6.78e-05	101	141	7	M1979
Pathway	BIOCARTA_NTHI_PATHWAY	MAPK14 MAPK11 MAP2K3 MAP2K6	7.33e-05	23	141	4	M2821
Pathway	BIOCARTA_HER2_PATHWAY	ERBB2 ERBB4 EGFR MAPK3	7.33e-05	23	141	4	M18719
Pathway	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	MAPK14 MAPK11 MAP2K3 MAP2K6	7.33e-05	23	141	4	M17243
Pathway	BIOCARTA_HER2_PATHWAY	ERBB2 ERBB4 EGFR MAPK3	7.33e-05	23	141	4	MM1480
Pathway	REACTOME_INTERLEUKIN_17_SIGNALING	IL17RB MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	7.56e-05	71	141	6	M27382
Pathway	KEGG_MAPK_SIGNALING_PATHWAY	PDGFA CACNA1F CACNB1 CACNB4 MAPK14 EGFR MAP3K13 MAPK3 MAPK11 MAP2K3 MAP2K6	7.66e-05	267	141	11	M10792
Pathway	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	MAPK14 MAPK11 MAP2K3 MAP2K6	8.72e-05	24	141	4	MM15133
Pathway	BIOCARTA_KERATINOCYTE_PATHWAY	MAPK14 EGFR MAPK3 MAP2K3 MAP2K6	9.19e-05	46	141	5	M19118
Pathway	BIOCARTA_KERATINOCYTE_PATHWAY	MAPK14 EGFR MAPK3 MAP2K3 MAP2K6	9.19e-05	46	141	5	MM1428
Pathway	REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS	MAPK14 MAPK3 MAPK11	1.12e-04	10	141	3	MM15135
Pathway	REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS	MAPK14 MAPK3 MAPK11	1.12e-04	10	141	3	M13962
Pathway	PID_P38_MKK3_6PATHWAY	MAPK14 MAPK11 MAP2K3 MAP2K6	1.21e-04	26	141	4	M20
Pathway	WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	1.25e-04	49	141	5	M39543
Pathway	WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING	MAPK14 EGFR MAPK11 MAP2K3 MAP2K6	1.51e-04	51	141	5	M39438
Pathway	REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING	ERBB2 ERBB4 EGFR	1.52e-04	11	141	3	MM15478
Pathway	BIOCARTA_MAPK_PATHWAY	MAPK14 MAP3K13 MAPK3 MAPK11 MAP2K3 MAP2K6	1.58e-04	81	141	6	M13863
Pathway	WP_MAPK_CASCADE	MAPK14 MAPK3 MAP2K3 MAP2K6	1.63e-04	28	141	4	MM15976
Pathway	PID_P38_ALPHA_BETA_PATHWAY	MAPK14 MAPK11 MAP2K3 MAP2K6	2.15e-04	30	141	4	M76
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	ERBB2 ERBB4 EGFR	2.60e-04	13	141	3	MM15320
Pathway	REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING	ERBB2 ERBB4 EGFR	2.60e-04	13	141	3	M27729
Pathway	REACTOME_INTERLEUKIN_17_SIGNALING	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	3.02e-04	59	141	5	MM15128
Pathway	WP_MAPK_CASCADE	MAPK14 MAPK3 MAP2K3 MAP2K6	3.13e-04	33	141	4	M39594
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB4 EGFR	3.29e-04	14	141	3	MM14761
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB4 EGFR	3.29e-04	14	141	3	MM14531
Pathway	PID_MAPK_TRK_PATHWAY	MAPK14 MAPK3 MAP2K3 MAP2K6	3.52e-04	34	141	4	M270
Pathway	BIOCARTA_FMLP_PATHWAY	MAPK14 MAPK3 MAP2K3 MAP2K6	3.52e-04	34	141	4	MM1399
Pathway	BIOCARTA_FMLP_PATHWAY	MAPK14 MAPK3 MAP2K3 MAP2K6	3.52e-04	34	141	4	M10287
Pathway	PID_ERBB_NETWORK_PATHWAY	ERBB2 ERBB4 EGFR	4.08e-04	15	141	3	M201
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	ERBB2 ERBB4 EGFR	4.08e-04	15	141	3	M27608
Pathway	WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY	HDAC7 MAPK14 MAPK3 MAP2K3 MAP2K6 CDK7	4.70e-04	99	141	6	MM15905
Pathway	WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY	MAPK14 MAPK3 MAP2K3 MAP2K6	4.90e-04	37	141	4	M42558
Pathway	KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY	ERBB2 EGFR MAPK3	4.99e-04	16	141	3	M47381
Pathway	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB4 EGFR	4.99e-04	16	141	3	M562
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB4 EGFR	4.99e-04	16	141	3	M570
Pathway	WP_RAC1PAK1P38MMP2_PATHWAY	ERBB2 MAPK14 EGFR MAPK3 MAPK11	5.86e-04	68	141	5	M39456
Pathway	REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA	EXOSC2 MAPK14 MAPK11	6.01e-04	17	141	3	M959
Pathway	KEGG_MEDICUS_REFERENCE_IL1_IL1R_P38_SIGNALING_PATHWAY	MAPK14 MAP2K3 MAP2K6	6.01e-04	17	141	3	M47470
Pathway	WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY	HDAC7 MAPK14 MAPK3 MAP2K3 MAP2K6 CDK7	6.12e-04	104	141	6	M39625
Pathway	PID_VEGFR1_2_PATHWAY	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	6.27e-04	69	141	5	M237
Pathway	PID_ANTHRAX_PATHWAY	MAPK3 MAP2K3 MAP2K6	7.16e-04	18	141	3	M267
Pathway	REACTOME_ERK_MAPK_TARGETS	MAPK14 MAPK3 MAPK11	8.44e-04	19	141	3	MM14780
Pathway	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER	USP45 CUL4B SUMO3 CDK7	8.74e-04	43	141	4	M1005
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_USP8_TO_EGFR_ERK_ACTH_SIGNALING_PATHWAY	EGFR MAPK3	9.74e-04	5	141	2	M49028
Pathway	WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER	EGFR MAPK3	9.74e-04	5	141	2	M39621
Pathway	REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1	UBA2 SUMO3	9.74e-04	5	141	2	M27223
Pathway	BIOCARTA_MAPK_PATHWAY	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	9.75e-04	76	141	5	MM1433
Pathway	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER	USP45 CUL4B SUMO3 CDK7	1.04e-03	45	141	4	MM15302
Pathway	WP_ESC_PLURIPOTENCY_PATHWAYS	PDGFA BMPR1A BMPR1B EGFR MAP2K3 MAP2K6	1.08e-03	116	141	6	MM15863
Pathway	WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING	MAPK14 CSF2RB EGFR MAPK3 MAPK11	1.10e-03	78	141	5	M39824
Pathway	WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS	MAPK14 MAPK3 MAP2K3 MAP2K6	1.13e-03	46	141	4	M39805
Pathway	WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS	PDGFA BMPR1A BMPR1B EGFR MAP2K3 MAP2K6	1.13e-03	117	141	6	M39530
Pathway	WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN	MAPK3 MAP2K3 MAP2K6	1.14e-03	21	141	3	M48342
Pathway	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	1.16e-03	79	141	5	M11816
Pathway	WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES	BMPR1A BMPR1B GLI2 MAPK14 MAPK3 MAPK11	1.19e-03	118	141	6	M39852
Pathway	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	TXNIP MAPK14 MAPK11 MAP2K6	1.23e-03	47	141	4	MM14664
Pathway	REACTOME_CELLULAR_SENESCENCE	KAT5 MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	1.24e-03	119	141	6	MM14901
Pathway	WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES	MAPK14 MAP2K3 MAP2K6	1.31e-03	22	141	3	M39773
Pathway	REACTOME_ERK_MAPK_TARGETS	MAPK14 MAPK3 MAPK11	1.31e-03	22	141	3	M13408
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB4 EGFR	1.31e-03	22	141	3	M26929
Pathway	REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER	USP45 CUL4B RFC3 SUMO3 CDK7	1.45e-03	83	141	5	MM15305
Pathway	WP_GLIOBLASTOMA_SIGNALING	ERBB2 EGFR MAPK3 MAP2K3 MAP2K6	1.45e-03	83	141	5	M39637
Pathway	BIOCARTA_SUMO_PATHWAY	UBA2 SUMO3	1.45e-03	6	141	2	M22055
Pathway	KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY	MAP2K3 MAP2K6	1.45e-03	6	141	2	M47636
Pathway	REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER	USP45 CUL4B RFC3 SUMO3 CDK7	1.53e-03	84	141	5	M27594
Pathway	REACTOME_MYD88_MAL_TIRAP_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	1.61e-03	85	141	5	MM14645
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES	MAPK14 MAPK3 MAPK11	1.70e-03	24	141	3	M27553
Pathway	WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART	MAPK14 MAPK11 MAP2K3	1.70e-03	24	141	3	M39576
Pathway	BIOCARTA_TOLL_PATHWAY	MAPK14 MAP2K3 MAP2K6	1.70e-03	24	141	3	MM1518
Pathway	BIOCARTA_STRESS_PATHWAY	MAPK14 MAP2K3 MAP2K6	1.70e-03	24	141	3	MM1515
Pathway	KEGG_MEDICUS_REFERENCE_TNF_P38_SIGNALING_PATHWAY	MAPK14 MAP2K3 MAP2K6	1.70e-03	24	141	3	M47568
Pathway	BIOCARTA_STRESS_PATHWAY	MAPK14 MAP2K3 MAP2K6	1.70e-03	24	141	3	M9670
Pathway	BIOCARTA_TFF_PATHWAY	ERBB2 EGFR MAPK3	1.70e-03	24	141	3	M15926
Pathway	KEGG_ENDOMETRIAL_CANCER	ERBB2 APC2 EGFR MAPK3	1.79e-03	52	141	4	M19877
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES	MAPK14 MAPK3 MAPK11	1.92e-03	25	141	3	MM15269
Pathway	PID_LYMPH_ANGIOGENESIS_PATHWAY	MAPK14 MAPK3 MAPK11	1.92e-03	25	141	3	M274
Pathway	WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION	MAPK3 MAP2K3 MAP2K6	1.92e-03	25	141	3	M39574
Pathway	KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL	CACNA1F CACNB1 CACNB4	1.92e-03	25	141	3	M47948
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL	ERBB2 ERBB4 EGFR	1.92e-03	25	141	3	M47934
Pathway	BIOCARTA_TOLL_PATHWAY	MAPK14 MAP2K3 MAP2K6	1.92e-03	25	141	3	M984
Pathway	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	MAPK14 MAPK11 MAP2K3 MAP2K6	1.92e-03	53	141	4	M3812
Pathway	PID_AR_TF_PATHWAY	KAT5 HDAC7 MAPK14 MAP2K6	1.92e-03	53	141	4	M151
Pathway	REACTOME_FRUCTOSE_METABOLISM	AKR1B1 SORD	2.02e-03	7	141	2	M27506
Pathway	REACTOME_FRUCTOSE_METABOLISM	AKR1B1 SORD	2.02e-03	7	141	2	MM15231
Pathway	BIOCARTA_SUMO_PATHWAY	UBA2 SUMO3	2.02e-03	7	141	2	MM1570
Pathway	REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS	SLC12A6 SLC12A7	2.02e-03	7	141	2	M27339
Pathway	REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS	SLC12A6 SLC12A7	2.02e-03	7	141	2	MM15081
Pathway	REACTOME_P38MAPK_EVENTS	MAPK14 MAPK11	2.02e-03	7	141	2	MM14672
Pathway	REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9	UBA2 SUMO3	2.02e-03	7	141	2	M27224
Pathway	KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY	ERBB2 EGFR	2.02e-03	7	141	2	M47431
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CYLC1 GLS2 PDGFA RAPH1 CENPC SSR2 TASOR2 BMPR1A BMPR1B SACS STARD9 KMT2A DMD BAHCC1 SLC12A6 CCDC185 SMCHD1 ABCB5 ZFC3H1 PPL CAPN11 CCDC27 TMPO MACF1 IFT122 ZNF350 RIMS1 ATP2B3 RPL6 ZNF292	1.46e-09	1442	202	30	35575683
Pubmed	p150(Glued), Dynein, and microtubules are specifically required for activation of MKK3/6 and p38 MAPKs.	MAPK14 MAP2K3 MAP2K6 DNAH11	5.50e-09	5	202	4	15375157
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	PCSK5 SETD1A ERBB2 APC2 GFPT1 BMPR1A BMPR1B KMT2A CUL4B TUT4 KAT5 DNAH10 CAPN11 MAPK14 EGFR PRMT3 MAPK3 MAPK11 MAP2K6 DNAH11	1.20e-08	730	202	20	34857952
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RAPH1 YTHDC1 REXO1 FANCD2 ZC3H11A SVIL IQSEC1 KMT2A SF3B2 CUL4B ARFGEF2 UBA2 HDAC7 EXOSC2 PPL EGFR TMPO RIMS1 MAPK3 SNRNP200	3.13e-08	774	202	20	15302935
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	TRPM7 INPP5B TASOR2 ZC3H11A SYDE2 FLRT2 CAMSAP1 MGA ARFGEF2 CEP192 RFC3 PPL CCDC88A EGFR TMPO PRR11 SNRNP200 RPL6 SNX1 RPL8	3.34e-08	777	202	20	35844135
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CDR2 ERBB2 ERBB4 RAPH1 TRPM7 ARHGEF16 STARD9 SYDE2 SVIL IQSEC1 KMT2A CAMSAP1 PIBF1 CEP192 HDAC7 E2F8 CCDC88A ARHGEF1 ANKRD11 MACF1 OTOG	3.71e-08	861	202	21	36931259
Pubmed	The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice.	BMPR1B MAPK14 MAPK11 MAP2K6	3.81e-08	7	202	4	20551513
Pubmed	Regulation of a mitogen-activated protein kinase kinase kinase, MLTK by PKN.	MAPK14 MAPK11 MAP2K3 MAP2K6	7.59e-08	8	202	4	12761180
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	NUSAP1 GTPBP4 CENPC YTHDC1 GFPT1 FANCD2 ZC3H11A KMT2A AKR1B1 PLRG1 SF3B2 CUL4B KAT5 SMCHD1 UBA2 DNAJB4 RFC3 EXOSC2 SUMO3 MAP2K3 SORD CDK7	1.32e-07	1014	202	22	32416067
Pubmed	ERBB3-dependent AKT and ERK pathways are essential for atrioventricular cushion development in mouse embryos.	ERBB2 ERBB4 EGFR MAPK3	1.36e-07	9	202	4	34714866
Pubmed	Mxi2 promotes stimulus-independent ERK nuclear translocation.	MAPK14 MAPK3 MAP2K3 MAP2K6	1.36e-07	9	202	4	17255949
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PDE2A TRPM7 APC2 CMYA5 FRMD4B GFPT1 SACS SYT4 FHL1 SF3B2 CFAP91 WASHC4 TNPO2 ARFGEF2 DYNC2I1 ZFC3H1 ZNF251 MACF1 TMEM131 SUMO3 IFT122 ZNF350 SNRNP200 SNX1 ZNF292	1.39e-07	1285	202	25	35914814
Pubmed	p38α Signaling Induces Anoikis and Lumen Formation During Mammary Morphogenesis.	MAPK14 MAP2K3 MAP2K6	1.93e-07	3	202	3	21610252
Pubmed	A diacylglycerol kinase inhibitor, R59022, stimulates glucose transport through a MKK3/6-p38 signaling pathway in skeletal muscle cells.	MAPK14 MAP2K3 MAP2K6	1.93e-07	3	202	3	17588539
Pubmed	TXNIP interaction with the Her-1/2 pathway contributes to overall survival in breast cancer.	ERBB2 TXNIP EGFR	1.93e-07	3	202	3	25605021
Pubmed	Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase kinase cascade.	MAPK14 MAP2K3 MAP2K6	1.93e-07	3	202	3	8626699
Pubmed	Activation of the MAP kinase homologue RK requires the phosphorylation of Thr-180 and Tyr-182 and both residues are phosphorylated in chemically stressed KB cells.	MAPK14 MAP2K3 MAP2K6	1.93e-07	3	202	3	7750576
Pubmed	p38 kinase-mediated transactivation of the epidermal growth factor receptor is required for dedifferentiation of renal epithelial cells after oxidant injury.	MAPK14 EGFR MAP2K3	1.93e-07	3	202	3	15797859
Pubmed	Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma.	ERBB2 ERBB4 EGFR	1.93e-07	3	202	3	15026342
Pubmed	Activin A induction of erythroid differentiation through MKK6-p38alpha/p38beta pathway is inhibited by follistatin.	MAPK14 MAPK11 MAP2K6	1.93e-07	3	202	3	20162623
Pubmed	p38α MAPK is required for tooth morphogenesis and enamel secretion.	MAPK14 MAP2K3 MAP2K6	1.93e-07	3	202	3	25406311
Pubmed	Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells.	ERBB2 ERBB4 EGFR	1.93e-07	3	202	3	12532415
Pubmed	MKK3 and -6-dependent activation of p38alpha MAP kinase is required for cytoskeletal changes in pulmonary microvascular endothelial cells induced by ICAM-1 ligation.	MAPK14 MAP2K3 MAP2K6	1.93e-07	3	202	3	15516490
Pubmed	Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons.	MAPK14 MAP2K3 MAP2K6	1.93e-07	3	202	3	15644321
Pubmed	ErbB receptors protect the perfused heart against injury induced by epinephrine combined with low-flow ischemia.	ERBB2 ERBB4 EGFR	1.93e-07	3	202	3	19370475
Pubmed	Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes.	MAPK14 MAP2K3 MAP2K6	1.93e-07	3	202	3	15778394
Pubmed	Absence of EGFR, ERBB2 and ERBB4 mutation homologous to the oncogenic ERBB3 Val-104 mutation in colorectal cancers.	ERBB2 ERBB4 EGFR	1.93e-07	3	202	3	24862237
Pubmed	Differential activation of p38MAPK isoforms by MKK6 and MKK3.	MAPK14 MAP2K3 MAP2K6	1.93e-07	3	202	3	20004242
Pubmed	Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis.	ERBB2 ERBB4 EGFR	1.93e-07	3	202	3	23100016
Pubmed	p38 MAPK α and β isoforms differentially regulate plasma membrane localization of MRP2.	MAPK14 MAP2K3 MAP2K6	1.93e-07	3	202	3	27012769
Pubmed	Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry.	ERBB2 ERBB4 EGFR	1.93e-07	3	202	3	25468910
Pubmed	Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC.	MAPK14 MAP2K3 MAP2K6	1.93e-07	3	202	3	22164285
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	ERBB2 ERBB4 KCNH7 GLS2 GFPT1 ITIH2 DMD SF3B2 WASHC4 EGFR MAP2K3 SNRNP200	2.53e-07	304	202	12	32235678
Pubmed	Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation.	BMPR1A BMPR1B MAPK14 EGFR MAPK3	3.75e-07	26	202	5	12805214
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	NUSAP1 GTPBP4 ZC3H11A PLRG1 TICRR DDX31 SMCHD1 ZFC3H1 RFC3 EXOSC2 PDHX MCM9 CKAP2L TMPO MACF1 SNRNP200 RPL6 RPL8	5.51e-07	759	202	18	35915203
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	NUSAP1 GTPBP4 YTHDC1 FANCA MSANTD3 ZC3H11A KMT2A MGA PLRG1 MNT SF3B2 TICRR KAT5 SMCHD1 ZFC3H1 RFC3 EXOSC2 ANKRD11 TMPO SUMO3 NUP188 SNRNP200 RPL6 RPL8	5.93e-07	1294	202	24	30804502
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	TASOR2 ZC3H11A KMT2A MGA SMCHD1 TMPO SUMO3	7.32e-07	86	202	7	37253089
Pubmed	Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	24557338
Pubmed	Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	23991224
Pubmed	MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway.	MAPK14 MAP2K3 MAP2K6	7.69e-07	4	202	3	8622669
Pubmed	Expression of epidermal growth factors, erbBs, in the nasal mucosa of patients with chronic hypertrophic rhinitis.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	22327010
Pubmed	Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	17177598
Pubmed	The relevance of EGFR, ErbB receptors and neuregulins in human adipocytes and adipose tissue in obesity.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	36411648
Pubmed	HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	21203579
Pubmed	ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	19263517
Pubmed	Analysis of ErbB receptors in pulmonary carcinoid tumors.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	19447869
Pubmed	Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	18985033
Pubmed	Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	9556621
Pubmed	Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	20204273
Pubmed	Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation.	MAPK14 EGFR MAPK11	7.69e-07	4	202	3	20188673
Pubmed	WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	12807903
Pubmed	HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	27069134
Pubmed	Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	26021752
Pubmed	Mechanism of p38 MAP kinase activation in vivo.	MAPK14 MAP2K3 MAP2K6	7.69e-07	4	202	3	12893778
Pubmed	The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	16685269
Pubmed	Translational control of NKT cell cytokine production by p38 MAPK.	MAPK14 MAP2K3 MAP2K6	7.69e-07	4	202	3	21368234
Pubmed	p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration.	MAPK14 EGFR MAPK11	7.69e-07	4	202	3	17139251
Pubmed	The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy.	MAPK14 MAP2K3 MAP2K6	7.69e-07	4	202	3	11593045
Pubmed	The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	15345710
Pubmed	Phospholipase C-beta 2 interacts with mitogen-activated protein kinase kinase 3.	MAPK14 MAP2K3 MAP2K6	7.69e-07	4	202	3	12054652
Pubmed	Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	12621152
Pubmed	Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	22854050
Pubmed	The erbB/HER type 1 tyrosine kinase receptor family.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	9771475
Pubmed	Laminin-1 and epidermal growth factor family members co-stimulate fetal pancreas cell proliferation and colony formation.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	15733067
Pubmed	Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2.	MAPK14 MAP2K3 MAP2K6	7.69e-07	4	202	3	9768359
Pubmed	A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.	ERBB2 ERBB4 EGFR	7.69e-07	4	202	3	8816440
Pubmed	Arachidonic acid release by H2O2 mediated proliferation of mouse embryonic stem cells: involvement of Ca2+/PKC and MAPKs-induced EGFR transactivation.	MAPK14 EGFR MAPK3	1.91e-06	5	202	3	19199341
Pubmed	Dominance of ErbB-1 heterodimers in lung epithelial cells overexpressing ErbB-2. Both ErbB-1 and ErbB-2 contribute significantly to tumorigenicity.	ERBB2 ERBB4 EGFR	1.91e-06	5	202	3	10572067
Pubmed	Developmental profile of ErbB receptors in murine central nervous system: implications for functional interactions.	ERBB2 ERBB4 EGFR	1.91e-06	5	202	3	15682390
Pubmed	p38alpha isoform Mxi2 binds to extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase and regulates its nuclear activity by sustaining its phosphorylation levels.	MAPK14 MAPK3 MAP2K6	1.91e-06	5	202	3	12697810
Pubmed	Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.	ERBB2 ERBB4 EGFR	1.91e-06	5	202	3	25416285
Pubmed	ZAKα-driven ribotoxic stress response activates the human NLRP1 inflammasome.	MAPK14 MAPK11 MAP2K6	1.91e-06	5	202	3	35857590
Pubmed	Heparin-binding EGF-like growth factor shows transient left-right asymmetrical expression in mouse myotome pairs.	ERBB4 EGFR DNAH11	1.91e-06	5	202	3	15533812
Pubmed	H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells.	MAPK14 MAP2K3 MAP2K6	1.91e-06	5	202	3	15677464
Pubmed	Tissue interaction mediated by neuregulin-1 and ErbB receptors regulates epithelial morphogenesis of mouse embryonic submandibular gland.	ERBB2 ERBB4 EGFR	1.91e-06	5	202	3	15254894
Pubmed	Expression of epidermal growth factors and a tight junction protein in the nasal mucosa of patients with chronic hypertrophic rhinitis.	ERBB2 ERBB4 EGFR	1.91e-06	5	202	3	23137868
Pubmed	Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma.	ERBB2 ERBB4 EGFR	1.91e-06	5	202	3	22554477
Pubmed	Neuregulin-1 induces branching morphogenesis in the developing lung through a P13K signal pathway.	ERBB2 ERBB4 EGFR	1.91e-06	5	202	3	15524405
Pubmed	Segregation of receptor and ligand regulates activation of epithelial growth factor receptor.	ERBB2 ERBB4 EGFR	1.91e-06	5	202	3	12646923
Pubmed	MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation.	MAPK14 MAP2K3 MAP2K6	1.91e-06	5	202	3	35971771
Pubmed	Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family.	ERBB2 ERBB4 EGFR	1.91e-06	5	202	3	26886748
Pubmed	MEK2 controls the activation of MKK3/MKK6-p38 axis involved in the MDA-MB-231 breast cancer cell survival: Correlation with cyclin D1 expression.	MAPK14 MAP2K3 MAP2K6	1.91e-06	5	202	3	27181679
Pubmed	Synapse-associated expression of an acetylcholine receptor-inducing protein, ARIA/heregulin, and its putative receptors, ErbB2 and ErbB3, in developing mammalian muscle.	ERBB2 ERBB4 EGFR	1.91e-06	5	202	3	7589796
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	GTPBP4 CENPC TRPM7 SACS PIBF1 PLRG1 SF3B2 DDX31 DNAJB4 CEP192 ZFC3H1 PDHX CCDC88A EGFR ANKRD11 TMPO MACF1 TMEM131 IFT122 PRR11 SNRNP200 RPL6 VPS13B SNX1 RPL8	2.00e-06	1487	202	25	33957083
Pubmed	Fibulin-1 is required during cardiac ventricular morphogenesis for versican cleavage, suppression of ErbB2 and Erk1/2 activation, and to attenuate trabecular cardiomyocyte proliferation.	ERBB2 ERBB4 EGFR MAPK3	2.48e-06	17	202	4	22183742
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	ERBB4 IQSEC1 CAMSAP1 TNPO2 PDHX CCDC88A ABI2 MACF1 MAPK3	2.51e-06	197	202	9	36604605
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	TRPM7 CACNA1F CACNB1 CACNB4 ATP2B3	2.70e-06	38	202	5	30786075
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	NUSAP1 LZTR1 RAPH1 CENPC FANCD2 KIF15 SVIL DMD PIBF1 GPD2 DDX31 CEP192 CCDC88A MAPK14 EGFR ABI2 TMPO MAPK3 MAPK11 SLC12A7	3.64e-06	1049	202	20	27880917
Pubmed	Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice.	ERBB2 ERBB4 EGFR	3.81e-06	6	202	3	32335999
Pubmed	The ectodomain of cadherin-11 binds to erbB2 and stimulates Akt phosphorylation to promote cranial neural crest cell migration.	ERBB2 ERBB4 EGFR	3.81e-06	6	202	3	29190819
Pubmed	Mechanisms of kringle fragment of urokinase-induced vascular smooth muscle cell migration.	MAPK14 EGFR MAPK3	3.81e-06	6	202	3	17574041
Pubmed	Mouse preimplantation embryo responses to culture medium osmolarity include increased expression of CCM2 and p38 MAPK activation.	MAPK14 MAP2K3 MAP2K6	3.81e-06	6	202	3	17214902
Pubmed	LDLs stimulate p38 MAPKs and wound healing through SR-BI independently of Ras and PI3 kinase.	MAPK14 MAP2K3 MAP2K6	3.81e-06	6	202	3	18757346
Pubmed	Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.	MAPK14 MAP2K3 MAP2K6	3.81e-06	6	202	3	12589052
Pubmed	Modulation of Erbb2 signaling during development: a threshold level of Erbb2 signaling is required for development.	ERBB2 ERBB4 EGFR	3.81e-06	6	202	3	15496447
Pubmed	Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.	MAPK14 MAP2K3 MAP2K6	3.81e-06	6	202	3	11062068
Pubmed	Stress-activated kinase pathway alteration is a frequent event in bladder cancer.	MAPK14 MAP2K3 MAP2K6	3.81e-06	6	202	3	22154358
Pubmed	LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.	ERBB2 ERBB4 EGFR	3.81e-06	6	202	3	15282549
Pubmed	Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland.	ERBB2 ERBB4 EGFR	3.81e-06	6	202	3	11278868
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	NUSAP1 CMYA5 GFPT1 FANCD2 KIF15 CUL4B WASHC4 ARFGEF2 UBA2 DNAJB4 RFC3 EXOSC2 MAPK14 ABI2 ARHGEF1 MACF1 AKAP10 PRMT3 SUMO3 NUP188 SNRNP200 SNX1 RPL8 SORD	4.50e-06	1455	202	24	22863883
Interaction	YWHAZ interactions	CDR2 ERBB2 RAPH1 TRPM7 ARHGEF16 FANCD2 KIF15 STARD9 SYDE2 SVIL KMT2A CEP126 CAMSAP1 FHL1 AKR1B1 SF3B2 GP1BA TICRR DNAJB4 CEP192 HDAC7 RGS3 E2F8 CCDC88A CSF2RB EGFR ABI2 MACF1 MAP2K3 RUBCN OTOG CDK7	2.09e-06	1319	199	32	int:YWHAZ
Interaction	EPHA2 interactions	ERBB2 PDE2A ERBB4 PDGFA NPHP4 ARHGEF16 FARP2 FANCD2 DMD SLC12A6 ABCB5 BLZF1 CCDC88A MAPK14 EGFR ABI2 MACF1 SLC12A7 MAP2K3 MAP2K6 SNX1	9.47e-06	719	199	21	int:EPHA2
Interaction	YWHAG interactions	GTPBP4 CDR2 RAPH1 TRPM7 ARHGEF16 FARP2 FANCD2 KIF15 STARD9 SYDE2 SVIL IQSEC1 KMT2A CAMSAP1 PIBF1 TICRR KAT5 CEP192 HDAC7 E2F8 CCDC88A ARHGEF1 ANKRD11 MACF1 MAPK3 SNRNP200 RUBCN OTOG CDK7	1.51e-05	1248	199	29	int:YWHAG
Interaction	TGFA interactions	ERBB2 ERBB4 BMPR1A GPD2 TNPO2 EGFR PRR11	2.47e-05	87	199	7	int:TGFA
Interaction	UHRF2 interactions	TASOR2 FANCD2 ZC3H11A KMT2A MGA CUL4B KAT5 SMCHD1 TMPO SUMO3	3.11e-05	200	199	10	int:UHRF2
Interaction	SMAD1 interactions	ERBB2 USP45 BMPR1A CAMSAP1 MGA AKR1B1 SF3B2 ZNF251 KLF10 MAP2K3 CDK7	3.13e-05	243	199	11	int:SMAD1
Interaction	PLCB2 interactions	TRPM7 MAPK14 MAP2K3 MAP2K6	3.18e-05	19	199	4	int:PLCB2
GeneFamily	Erb-b2 receptor tyrosine kinases	ERBB2 ERBB4 EGFR	1.81e-06	4	140	3	1096
GeneFamily	Mitogen-activated protein kinases	MAPK14 MAPK3 MAPK11	1.23e-04	13	140	3	651
GeneFamily	Calcium voltage-gated channel subunits	CACNA1F CACNB1 CACNB4	1.04e-03	26	140	3	253
GeneFamily	Mitogen-activated protein kinase kinases	MAP2K3 MAP2K6	1.22e-03	7	140	2	653
GeneFamily	Basic helix-loop-helix proteins\|MAX dimerization proteins	MGA MNT	1.22e-03	7	140	2	637
GeneFamily	Type 1 receptor serine/threonine kinases	BMPR1A BMPR1B	1.22e-03	7	140	2	345
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	CMYA5 ARFGEF2 AKAP10	1.43e-03	29	140	3	396
GeneFamily	EF-hand domain containing\|Plakins	PPL MACF1	1.62e-03	8	140	2	939
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ABR ARHGEF16 FARP2 ARHGEF1	1.71e-03	66	140	4	722
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ABR SYDE2 RGS3	2.69e-03	36	140	3	823
Coexpression	GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_UP	NUSAP1 GTPBP4 PDGFA FANCA DMD IL17RB GPD2 TNPO2 RFC3 CSF2RB MAPK11 CDK7	8.00e-06	324	200	12	M41138
Coexpression	HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP	NUSAP1 KIF15 TICRR E2F8 CKAP2L PRR11	1.35e-05	68	200	6	M41108
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	NUSAP1 KCNH7 FANCA GREB1L FANCD2 CAMSAP1 TICRR UBA2 ZKSCAN2 E2F8 SLC9A5 ABI2 CKAP2L TMPO SUMO3 NUP188 PRR11	2.01e-05	680	200	17	MM456
Coexpression	GSE27786_NKCELL_VS_MONO_MAC_UP	SSR2 CMYA5 FARP2 SACS MGA TXNIP KLF10 ABI2 ANKRD11	2.46e-05	200	200	9	M4860
Coexpression	GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP	INPP5B FRMD4B AKR1B1 WASHC4 CKAP2L SUMO3 ZNF518B PRR11 SORD	2.46e-05	200	200	9	M8959
Coexpression	GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP	CDR2 FARP2 STARD9 CUL4B TICRR EXOSC2 CCDC34 TMPO ZNF518B	2.46e-05	200	200	9	M6542
Coexpression	DESCARTES_FETAL_CEREBRUM_ASTROCYTES	FREM1 GREB1L SPATA17 USH1C TNFRSF11B ZBBX CCDC198 EGFR OTOG	3.10e-05	206	200	9	M40171
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	CENPC BMPR1A SACS FLRT2 DMD PIBF1 MNT TUT4 WASHC4 SMCHD1 MAPK14 KLF10 EGFR MACF1 AKAP10 TMEM131 PRMT3 VPS13B ZNF292	3.33e-05	856	200	19	M4500
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	ERBB4 TRPM7 ATP9B ABCA10 FREM1 SVIL CACNB4 CCDC198 VPS13B	3.34e-05	208	200	9	M39233
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	NUSAP1 FANCA FANCD2 IL17RB TICRR RFC3 EXOSC2 E2F8 CCDC34 TMPO PRR11	4.13e-05	323	200	11	M2156
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	PDGFA MSANTD3 SACS FLRT2 DMD FHL1 AKR1B1 CUL4B WASHC4 DNAJB4 CCDC88A EGFR CKAP2L	6.40e-05	465	200	13	M9192
Coexpression	GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP	PDE2A ARHGEF16 FREM1 FLRT2 DDX31 SLC12A7 CD96	6.81e-05	131	200	7	M8933
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	NUSAP1 CENPC TRPM7 FANCD2 KIF15 GLI2 CEP126 DMD CAMSAP1 PIBF1 FHL1 CUL4B TICRR TUT4 ZNF354A SMCHD1 ARFGEF2 DYNC2I1 ZDBF2 CEP192 E2F8 CCDC88A CCDC34 CKAP2L TMPO MACF1 ZNF518B PRR11 MAPK11 ZNF292	2.24e-06	1257	199	30	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	NUSAP1 ERBB4 CENPC TRPM7 FANCD2 BMPR1B KIF15 GLI2 CEP126 DMD CAMSAP1 PIBF1 FHL1 CUL4B TICRR TUT4 ZNF354A SMCHD1 ARFGEF2 DYNC2I1 ZDBF2 CEP192 E2F8 CCDC88A CCDC34 CKAP2L TMPO MACF1 ZNF518B PRR11 MAPK11 ZNF292	5.82e-06	1459	199	32	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	NUSAP1 PIBF1 CMTM4 ARFGEF2 DYNC2I1 ZDBF2 CEP192 CCDC88A CKAP2L MACF1	1.07e-05	186	199	10	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	NUSAP1 CENPC TRPM7 IGSF10 BMPR1B KIF15 CEP126 PIBF1 CUL4B TICRR TUT4 DDX31 SMCHD1 ARFGEF2 DYNC2I1 DNAJB4 ZDBF2 CEP192 RFC3 CCDC88A CCDC34 CKAP2L TMPO MACF1 ZNF518B RNF207 RPL6 ZNF292	1.44e-05	1241	199	28	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	PCSK5 ERBB4 RAPH1 IL1RL2 FRMD4B GFPT1 FREM1 GREB1L FANCD2 IGSF10 STARD9 GLI2 SVIL CUL4B TUT4 DNAJB4 ZDBF2 EGFR PRR11 CDK7	3.81e-05	768	199	20	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	alpha beta T cells, T.DN4.Th, Lin-/lo CD25- CD44- CD28+, Thymus, avg-3	NUSAP1 FANCD2 KIF15 SYDE2 IL17RB TICRR RFC3 E2F8 CKAP2L RORC PRR11 CD96 SORD	5.84e-05	376	199	13	GSM791154_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	PCSK5 ERBB4 IL1RL2 FRMD4B GFPT1 FREM1 GREB1L IGSF10 KIF15 GLI2 SVIL CUL4B DNAJB4 ZDBF2 CEP192 E2F8 EGFR CKAP2L ZNF518B PRR11	5.94e-05	793	199	20	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	NUSAP1 FANCA MGA MNT TICRR TUT4 CMTM4 ARFGEF2 DYNC2I1 TBC1D10A CKAP2L MACF1 TMEM131 ZNF292	6.09e-05	432	199	14	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	NUSAP1 ERBB4 CENPC TRPM7 NPHP4 KIF15 CEP126 DMD CAMSAP1 FHL1 CUL4B GPD2 TICRR TUT4 ZNF354A DYNC2I1 ZDBF2 ZFC3H1 BLZF1 E2F8 CCDC88A CCDC34 CKAP2L SUMO3 ZNF518B RIMS1 MAPK11 SLC12A7	8.27e-05	1370	199	28	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3	NUSAP1 FANCD2 KIF15 SYDE2 IL17RB TICRR RFC3 E2F8 CCDC34 CKAP2L RORC PRR11 CD96	1.01e-04	397	199	13	GSM791143_500
CoexpressionAtlas	alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3	NUSAP1 CENPC FANCD2 KIF15 IL17RB TICRR E2F8 CCDC34 CKAP2L TMPO RORC PRR11 CD96	1.03e-04	398	199	13	GSM399397_500
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	NUSAP1 ERBB4 CENPC TRPM7 IGSF10 BMPR1B KIF15 CEP126 PIBF1 CUL4B TICRR TUT4 DDX31 SMCHD1 ARFGEF2 DYNC2I1 DNAJB4 ZDBF2 CEP192 RFC3 CCDC88A CCDC34 CKAP2L TMPO MACF1 ZNF518B RNF207 RPL6 ZNF292	1.11e-04	1468	199	29	facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	NUSAP1 CENPC TRPM7 IL1RL2 FREM1 GREB1L IGSF10 BMPR1A KIF15 GLI2 CEP126 CAMSAP1 CUL4B TICRR TUT4 DYNC2I1 CEP192 CCDC88A CKAP2L TMPO TMEM131 IFT122 CFAP61 PRR11 RPL6 ZNF292	1.18e-04	1252	199	26	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	NUSAP1 CENPC TRPM7 FRMD4B FANCD2 KIF15 YJU2B CEP126 DMD CAMSAP1 FHL1 TICRR TUT4 ZNF354A DYNC2I1 ZDBF2 CEP192 E2F8 CCDC88A CKAP2L MACF1 RNF207 ZNF292	1.59e-04	1060	199	23	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3	NUSAP1 FANCD2 KIF15 SYDE2 IL17RB TICRR RFC3 E2F8 CCDC34 CKAP2L RORC PRR11 CD96	1.64e-04	417	199	13	GSM399403_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	NUSAP1 BMPR1B PIBF1 TUT4 DNAH10 CMTM4 ARFGEF2 DYNC2I1 ZDBF2 CEP192 RFC3 CCDC88A CKAP2L MACF1	2.37e-04	492	199	14	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	NUSAP1 GTPBP4 CDR2 RAPH1 YTHDC1 ZC3H11A PLRG1 MNT SMCHD1 ARFGEF2 UBA2 TMPO MACF1 TMEM131 ZNF292	2.93e-04	564	199	15	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	B cells, B1b.PC, IgD+ IgM+ CD19+ CD43+ CD5- CD45R+, Peritoneal Cavity, avg-2	IQSEC1 SLC37A2 SLC12A6 TUT4 ARFGEF2 WDFY4 PPL CSF2RB SLC28A2 MACF1 RUBCN	3.55e-04	337	199	11	GSM538228_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	NUSAP1 APC2 FANCA IGSF10 BMPR1B DMD PIBF1 TUT4 DNAH10 CMTM4 ARFGEF2 DYNC2I1 ZDBF2 CEP192 RFC3 CCDC88A CSF2RB EGFR CKAP2L MACF1 PRODH	3.57e-04	978	199	21	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1	CDR2 PLCXD2 IL1RL2 CHST10 DDX60 ARHGEF1 SLC28A2 MACF1 MAPK11 SLC12A7 CD96	3.64e-04	338	199	11	GSM403987_500
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	NUSAP1 FANCA FANCD2 KIF15 TICRR CEP192 RFC3 RGS3 CKAP2L TMPO PRR11	1.23e-09	190	202	11	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	NUSAP1 FANCA FANCD2 KIF15 TICRR RFC3 E2F8 CCDC34 CKAP2L TMPO PRR11	1.61e-09	195	202	11	926eb3fc5d028be936885bea0654a77db3107234
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 FANCA FANCD2 KIF15 TICRR RFC3 E2F8 CCDC34 CKAP2L TMPO PRR11	1.61e-09	195	202	11	75759fd7f925725f0ecd07214afcca5aa2158f9e
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	NUSAP1 FANCA FANCD2 KIF15 TICRR RFC3 E2F8 CKAP2L TMPO PRR11 CD96	1.61e-09	195	202	11	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NUSAP1 CENPC KIF15 WDFY4 E2F8 CCDC88A CCDC34 CKAP2L TMPO PRR11	5.40e-09	168	202	10	b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 KCNH7 FANCA FANCD2 KIF15 TICRR RFC3 E2F8 CKAP2L PRR11	1.05e-08	180	202	10	401df9cddcbca1eb8f0d2687bcacd98e95dc1493
ToppCell	10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T\|Liver / Manually curated celltypes from each tissue	NUSAP1 KIF15 TICRR RFC3 E2F8 CCDC27 CCDC34 C18orf63 CKAP2L TMPO	1.16e-08	182	202	10	81557cdc88777f3bd4e1dd18a760b08fc29122ef
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	NUSAP1 FANCA FANCD2 KIF15 TICRR CEP192 RFC3 RGS3 CKAP2L PRR11	2.04e-08	193	202	10	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NUSAP1 FANCA FANCD2 KIF15 TICRR RFC3 E2F8 CCDC34 CKAP2L PRR11	2.36e-08	196	202	10	73f951f7712e0aa3323676b9a4b7944d21d347c4
ToppCell	distal-Hematologic-Proliferating_Macrophage-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NUSAP1 FANCD2 KIF15 IL17RB TICRR RFC3 E2F8 CCDC34 CKAP2L PRR11	2.59e-08	198	202	10	2b0716e900bce54ad1825d6dcdaf4ebf31f355c4
ToppCell	MNPs-Dividing_Macrophages\|MNPs / lung cells shred on cell class, cell subclass, sample id	NUSAP1 FANCD2 KIF15 TICRR RFC3 E2F8 CCDC34 CKAP2L TMPO PRR11	2.72e-08	199	202	10	5952980d0ece5d73f3e9f340c56a38b34d2f2309
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NUSAP1 CENPC FANCA KIF15 TICRR E2F8 CCDC88A CKAP2L TMPO PRR11	2.85e-08	200	202	10	4cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NUSAP1 FANCA FANCD2 KIF15 TICRR RFC3 RGS3 E2F8 CKAP2L PRR11	2.85e-08	200	202	10	af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NUSAP1 FANCA FANCD2 KIF15 RFC3 E2F8 CCDC34 CKAP2L TMPO PRR11	2.85e-08	200	202	10	43571c9284d4e41402a2d1eefc1efe2ce8476d4a
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	NUSAP1 FANCA FANCD2 KIF15 RFC3 E2F8 CCDC34 CKAP2L TMPO PRR11	2.85e-08	200	202	10	8f9e76048ae6f45218a09a95a2c4b31e8a8937b2
ToppCell	Dividing_Macrophages-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	NUSAP1 FANCD2 KIF15 E2F8 CCDC88A CCDC34 CKAP2L TMPO PRR11	8.33e-08	169	202	9	bc859a103cad567caf50c3c3882d2d2017807c73
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CEP126 USP50 LRRC63 CFAP91 DNAH10 DYNC2I1 ZBBX CFAP61 DNAH11	8.33e-08	169	202	9	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue\|TCGA-Breast / Sample_Type by Project: Shred V9	PDE2A ABCA10 FREM1 IGSF10 STARD9 DMD FHL1 ABCB5 CAPN11	1.07e-07	174	202	9	0f3ec0d0d4344e10c9b48adc9174123f6402dc51
ToppCell	TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3\|TCGA-Breast / Sample_Type by Project: Shred V9	PDE2A ABCA10 FREM1 IGSF10 STARD9 DMD FHL1 ABCB5 CAPN11	1.07e-07	174	202	9	7f8f5fafae08676d2b90cab9802c3c9320f1370e
ToppCell	TCGA-Breast-Solid_Tissue_Normal\|TCGA-Breast / Sample_Type by Project: Shred V9	PDE2A ABCA10 FREM1 IGSF10 STARD9 DMD FHL1 ABCB5 CAPN11	1.07e-07	174	202	9	e2f240d60bffbe8e6d60f0bb405b231bd3c96875
ToppCell	TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue\|TCGA-Breast / Sample_Type by Project: Shred V9	PDE2A ABCA10 FREM1 IGSF10 STARD9 DMD FHL1 ABCB5 CAPN11	1.07e-07	174	202	9	1aadbf2642b6d1320ceabd92e6ff59e11f16c315
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GLS2 IL1RL2 FANCD2 KIF15 TICRR WDFY4 E2F8 PRR11 MAP2K6	1.18e-07	176	202	9	581045e61cdcdfa85701343d1a7c0a72a36606a7
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	NUSAP1 FANCA FANCD2 KIF15 TICRR E2F8 CKAP2L TMPO PRR11	1.80e-07	185	202	9	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYLC1 NUSAP1 ADRA1D KIF15 TICRR BLZF1 E2F8 CKAP2L	1.85e-07	134	202	8	4d8f7ddad02fe76a614771e115ebb8e04623ba85
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 FANCA FANCD2 KIF15 TICRR RFC3 E2F8 CKAP2L PRR11	1.97e-07	187	202	9	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	NUSAP1 FANCA FANCD2 NDST3 KIF15 TICRR RFC3 E2F8 RIMS1	2.26e-07	190	202	9	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NUSAP1 FANCA KIF15 TICRR RFC3 E2F8 CKAP2L TMPO CD96	2.36e-07	191	202	9	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	Dividing_Macrophages-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	NUSAP1 FANCD2 KIF15 TICRR E2F8 CCDC34 CKAP2L TMPO PRR11	2.47e-07	192	202	9	741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	SPATA17 CEP126 DMD CFAP91 DNAH10 DYNC2I1 ZBBX CFAP61 DNAH11	2.58e-07	193	202	9	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NUSAP1 FANCA KIF15 PROB1 TICRR RFC3 E2F8 CCDC34 CKAP2L	2.58e-07	193	202	9	cf680afddc08b6481f1b3eee9c57acfaebeac6f0
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	NUSAP1 FANCA FANCD2 KIF15 TICRR RFC3 E2F8 CKAP2L PRR11	2.69e-07	194	202	9	f9070035553bc68106a9e0bdf4b507715a138aba
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|367C / Donor, Lineage, Cell class and subclass (all cells)	NUSAP1 KIF15 IL17RB RFC3 E2F8 CCDC34 CKAP2L TMPO PRR11	2.69e-07	194	202	9	a12b64945e10f00aa983678a02586c59badc1570
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	NUSAP1 FANCA FANCD2 KIF15 TICRR RFC3 E2F8 CKAP2L PRR11	2.81e-07	195	202	9	1a5e814e12fe37287dbfc58189e1958e2c76b5da
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	BMPR1B SPATA17 CEP126 CFAP91 DNAH10 ZBBX VSTM2L CFAP61 DNAH11	2.81e-07	195	202	9	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NUSAP1 FANCA FANCD2 KIF15 TICRR RFC3 E2F8 CKAP2L PRR11	2.94e-07	196	202	9	1964c5003a0cb84539850a7cfe3bbb0e23a61d2d
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NUSAP1 FANCA FANCD2 KIF15 TICRR RFC3 E2F8 CKAP2L PRR11	3.07e-07	197	202	9	84ed777cdba569200a3ef1654d8a12f17fcfb7f1
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	NUSAP1 CENPC FRMD4B FANCD2 KIF15 CCDC34 CKAP2L TMPO PRR11	3.20e-07	198	202	9	629d674a9c9108c1acb3f7af57bbdbf34bb0528e
ToppCell	cycling_basal_cell\|World / shred by cell class for turbinate	NUSAP1 FANCA FANCD2 KIF15 TICRR RFC3 CKAP2L TMPO PRR11	3.20e-07	198	202	9	e86c1224f5b0890a50a25257628e90c790aae7cd
ToppCell	medial-Hematologic-Proliferating_Macrophage\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NUSAP1 FANCD2 KIF15 TICRR RFC3 E2F8 CCDC34 CKAP2L PRR11	3.20e-07	198	202	9	da6963184c32761c896a9b91a5321ad84b583736
ToppCell	severe-Lymphocytic-Prol._cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	NUSAP1 KIF15 TICRR RFC3 E2F8 CCDC34 CKAP2L TMPO PRR11	3.20e-07	198	202	9	4d8591eabb543ed789f963b507a07c560c76a7c9
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	NUSAP1 CENPC FRMD4B FANCD2 KIF15 CCDC34 CKAP2L TMPO PRR11	3.20e-07	198	202	9	5f0964c3aa7e1dc52cbb46e754078920b65bcb88
ToppCell	medial-2-Hematologic-Proliferating_Macrophage\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NUSAP1 FANCD2 KIF15 TICRR RFC3 E2F8 CCDC34 CKAP2L PRR11	3.20e-07	198	202	9	64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f
ToppCell	medial-Hematologic-Proliferating_Macrophage-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NUSAP1 FANCD2 KIF15 TICRR RFC3 E2F8 CCDC34 CKAP2L PRR11	3.20e-07	198	202	9	fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NUSAP1 FANCA FANCD2 KIF15 TICRR E2F8 CKAP2L TMPO PRR11	3.20e-07	198	202	9	f088badb90c6c2d916195f5649eda102119c9ac6
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NUSAP1 PDGFA FANCD2 KIF15 SACS E2F8 EGFR CCDC34 CKAP2L	3.20e-07	198	202	9	7225a6194c52b01c581e58d3cda107c4af96dc4f
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	NUSAP1 FANCA FANCD2 KIF15 RFC3 E2F8 CCDC34 CKAP2L PRR11	3.34e-07	199	202	9	a99516a5760f49a69b0fe45a9b2316e393252966
ToppCell	Dividing_Macrophages\|World / lung cells shred on cell class, cell subclass, sample id	NUSAP1 FANCD2 KIF15 TICRR E2F8 CCDC34 CKAP2L TMPO PRR11	3.34e-07	199	202	9	5c755b6876e164dc847ef7c723f850f227cf3a87
ToppCell	Transverse-B_cell-B_cell_cycling\|B_cell / Region, Cell class and subclass	FANCA KIF15 CEP192 RFC3 USH1C E2F8 EGFR CCDC34 MAPK11	3.34e-07	199	202	9	170ae68963d31f3b821b6f0e8f0c039bea0bc981
ToppCell	distal-Hematologic-Proliferating_Macrophage\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NUSAP1 FANCD2 KIF15 IL17RB TICRR E2F8 CCDC34 CKAP2L PRR11	3.48e-07	200	202	9	3835a8a9739b8cd5bf19c40765ef76907ac1ad38
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	NUSAP1 CENPC KIF15 TICRR E2F8 CCDC88A CKAP2L TMPO PRR11	3.48e-07	200	202	9	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CENPC YTHDC1 KMT2A DDX60 SMCHD1 ZFC3H1 ANKRD11 MACF1 ZNF292	3.48e-07	200	202	9	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NUSAP1 PDGFA KIF15 RFC3 EGFR CCDC34 CKAP2L TMPO PRR11	3.48e-07	200	202	9	0de9e7412a1725a8acd51820aa3135a112ced36c
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors_nGenesUnder4k\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	NUSAP1 FANCA FANCD2 KIF15 RFC3 CCDC34 CKAP2L TMPO PRR11	3.48e-07	200	202	9	8223d2c9b9e05b1d26e3de1bc0226d175af2e7b2
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	NUSAP1 FANCD2 KIF15 IL17RB RFC3 E2F8 CKAP2L TMPO PRR11	3.48e-07	200	202	9	203b9a5de4430713da01b3331e69381db449a3a0
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	NUSAP1 FANCD2 KIF15 IL17RB RFC3 E2F8 CKAP2L TMPO PRR11	3.48e-07	200	202	9	a854e19703dc920e48304541e2b06ed013292f3e
ToppCell	distal-Hematologic-Proliferating_Macrophage-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NUSAP1 FANCD2 KIF15 IL17RB TICRR E2F8 CCDC34 CKAP2L PRR11	3.48e-07	200	202	9	9c03a8da12d29618f72c429836c1d1bd84a78b12
ToppCell	distal-3-Hematologic-Proliferating_Macrophage\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NUSAP1 FANCD2 KIF15 IL17RB TICRR E2F8 CCDC34 CKAP2L PRR11	3.48e-07	200	202	9	1b65c97e8123d0572d31525d6a10bc7f16857959
ToppCell	(24)_B_cell_cycling\|World / shred on Cell_type and subtype	NUSAP1 KIF15 DMD RFC3 USH1C E2F8 EGFR CCDC34 CKAP2L	3.79e-07	202	202	9	a7c9b6b173701348ba35fbb975e0bdd3c1f1d5fe
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDR2 F8 FANCD2 PDHX E2F8 CCDC34 CKAP2L MAPK3	8.23e-07	163	202	8	3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 FANCA FANCD2 KIF15 TICRR E2F8 CKAP2L PRR11	9.88e-07	167	202	8	bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NUSAP1 CCDC168 ZC3H11A KIF15 CACNB1 E2F8 CKAP2L CD96	1.03e-06	168	202	8	a7eb28e15b591997f1aee09501cb20ae18beca08
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NUSAP1 FREM1 KIF15 FHL1 E2F8 CKAP2L TMPO PRR11	1.08e-06	169	202	8	563c267edaade0e5df192ad953801ef9768d4270
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KCNH7 FANCA FANCD2 KIF15 TICRR RFC3 E2F8 CKAP2L	1.08e-06	169	202	8	e7514956b2e4298222ec443f98b2f5289451786e
ToppCell	343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NUSAP1 KIF15 TICRR ZNF285 KDM4D CCDC34 CKAP2L PRR11	1.18e-06	171	202	8	4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 FANCA FANCD2 KIF15 FLRT2 E2F8 PRR11 MAPK11	1.18e-06	171	202	8	c2dbc439af28d4fabb24d57685b75b2e588819b0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 KCNH7 KIF15 TICRR RGS3 E2F8 CKAP2L PRR11	1.40e-06	175	202	8	876cea684faf42ff3eb4623ad6d7a1fb1276ee02
ToppCell	Dividing_Macrophages-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	NUSAP1 FANCD2 KIF15 TICRR E2F8 CCDC34 CKAP2L PRR11	1.60e-06	178	202	8	1893fadac2ec3d5de0a641e57b7b2f962012a9ba
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 FANCA FANCD2 KIF15 TICRR RFC3 CKAP2L TMPO	1.66e-06	179	202	8	88d44b04eb5c079531db663ed98ddb20b60feb9a
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NUSAP1 CENPC FANCD2 KIF15 CCDC34 CKAP2L TMPO PRR11	1.73e-06	180	202	8	5e1680088065be14447d5d5465f91f7edd071a1e
ToppCell	P15-Endothelial-proliferative_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NUSAP1 NPHP4 FANCA FANCD2 KIF15 CCDC34 CKAP2L TMPO	1.81e-06	181	202	8	0c5bc1660b8fc1e905ab4230202862de5be46ebd
ToppCell	P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NUSAP1 NPHP4 FANCA FANCD2 KIF15 CCDC34 CKAP2L TMPO	1.81e-06	181	202	8	f83565f09dd971c5cad2704a4a86bca0accd955e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 KIF15 TICRR RFC3 RGS3 E2F8 CKAP2L PRR11	1.88e-06	182	202	8	336cd05e46a741185ce3c59ee67a4b07fa6a5101
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NUSAP1 KIF15 TICRR CCDC34 CKAP2L TMPO PRR11 CD96	2.04e-06	184	202	8	8260e688ec42a1374727bc85dceb7edd19a8b662
ToppCell	Dividing_Macrophages-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	NUSAP1 FANCD2 KIF15 TICRR E2F8 CCDC34 CKAP2L PRR11	2.04e-06	184	202	8	f15ce786d25c6546804a6d1efcc2ad645f2ef54e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 FANCA FANCD2 KIF15 TICRR E2F8 CKAP2L PRR11	2.13e-06	185	202	8	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	SPATA17 CEP126 CFAP91 DNAH10 ZBBX VSTM2L CFAP61 DNAH11	2.13e-06	185	202	8	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CDR2 GREB1L SPATA17 LRRC63 TNFRSF11B CCDC198 EGFR DNAH11	2.21e-06	186	202	8	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 FANCA FANCD2 KIF15 TICRR E2F8 CKAP2L PRR11	2.21e-06	186	202	8	9feef5936985e936b3d88f9d1bb012abb6468570
ToppCell	Dividing_Macrophages-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	NUSAP1 KIF15 TICRR E2F8 CCDC34 CKAP2L TMPO PRR11	2.21e-06	186	202	8	0067eb78d4c7e32b9563550d9fcaf13445ee6a48
ToppCell	facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 FANCA FANCD2 KIF15 TICRR E2F8 CKAP2L PRR11	2.21e-06	186	202	8	89f5b06bc56674af304912d481ac697c7c870904
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 KIF15 TICRR WDFY4 E2F8 CCDC88A CKAP2L PRR11	2.30e-06	187	202	8	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ERBB4 CMYA5 GREB1L SVIL DMD FHL1 RGS3 VSTM2L	2.40e-06	188	202	8	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)\|MatrixFB / shred on cell class and cell subclass (v4)	NUSAP1 FANCA KIF15 E2F8 CCDC34 CKAP2L TMPO PRR11	2.40e-06	188	202	8	b240ea20750ffb825cb5fe41d06c632233406ab6
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPATA17 CEP126 CFAP91 DNAH10 ZBBX VSTM2L CFAP61 DNAH11	2.40e-06	188	202	8	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	Control-Epithelial-Ciliated\|Control / Disease state, Lineage and Cell class	SPATA17 CEP126 CFAP91 DNAH10 ZBBX VSTM2L CFAP61 DNAH11	2.49e-06	189	202	8	c007fccd08728db3ea99af9da91d67b9b16dabb3
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NUSAP1 CENPC FREM1 KIF15 CCDC34 CKAP2L TMPO PRR11	2.49e-06	189	202	8	d049f33115610bda4489968759f754730698b9cd
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NUSAP1 FANCD2 KIF15 TICRR E2F8 CKAP2L TMPO PRR11	2.49e-06	189	202	8	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPATA17 CEP126 CFAP91 DNAH10 ZBBX VSTM2L CFAP61 DNAH11	2.49e-06	189	202	8	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ERBB4 TRPM7 CMYA5 SVIL DMD TXNIP CFAP61 RNF207	2.49e-06	189	202	8	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	SPATA17 CEP126 CFAP91 DNAH10 ZBBX VSTM2L CFAP61 DNAH11	2.49e-06	189	202	8	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 FANCA KIF15 STARD9 TICRR E2F8 CKAP2L PRR11	2.59e-06	190	202	8	31de1727822e9818652946dfb962daee77ffad68
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NUSAP1 FANCA FANCD2 KIF15 RFC3 CCDC34 CKAP2L TMPO	2.70e-06	191	202	8	50854384fdaa0efa2e3227659d544ed09ac102f2
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	FANCA KMT2A TNPO2 CCDC88A ANKRD11 IFT122 PRR11 ZNF292	2.80e-06	192	202	8	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 KIF15 E2F8 KLF10 CCDC34 CKAP2L TMPO PRR11	2.80e-06	192	202	8	e8d47504b744040a762ec9b670a66cc060b2ae86
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	SPATA17 CEP126 CFAP91 DNAH10 ZBBX VSTM2L CFAP61 DNAH11	2.80e-06	192	202	8	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	IGSF10 CEP126 CFAP91 DNAH10 DYNC2I1 ZBBX EGFR DNAH11	2.91e-06	193	202	8	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	NUSAP1 FANCD2 KIF15 TICRR E2F8 CKAP2L TMPO PRR11	2.91e-06	193	202	8	81e6240cffb094b2aa3684fd0889b6497f47c4f0
ToppCell	3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac\|Lung / Manually curated celltypes from each tissue	NUSAP1 FANCD2 KIF15 RFC3 E2F8 CCDC34 CKAP2L PRR11	3.03e-06	194	202	8	a8ae49157ca3f9e8b3f1750a995aee012dc859b6
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 FANCA KIF15 E2F8 CCDC34 CKAP2L TMPO PRR11	3.03e-06	194	202	8	1a2090e997c70433d07f56bf7cb0a50c4151118c
ToppCell	COVID-19-kidney-Proliferating_T_cell\|kidney / Disease (COVID-19 only), tissue and cell type	NUSAP1 FANCA KIF15 TICRR RFC3 E2F8 CKAP2L CD96	3.15e-06	195	202	8	7e05e56f8d0a7a052830c7db12b10dace7d10760
Drug	pyrido[3,4-d]pyrimidine	ERBB2 ERBB4 EGFR	6.78e-07	3	201	3	CID014758064
Drug	SKF86002	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	1.89e-06	24	201	5	CID000005228
Drug	MDL-28842	MAPK14 EGFR MAPK3 MAPK11	2.76e-06	12	201	4	CID006441200
Drug	BIBX1382BS	ERBB2 ERBB4 EGFR MAP2K3 MAP2K6	2.89e-06	26	201	5	CID006918508
Drug	nonanal	PCSK5 GFPT1 AKR1B1 KAT5 B4GALNT2	5.10e-06	29	201	5	CID000031289
Drug	MMP-2 Inhibitor I	ERBB2 MAPK14 MAPK3 MAPK11	7.46e-06	15	201	4	CID000004220
Drug	Rescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A	LZTR1 MGA IL17RB GPD2 SMCHD1 E2F8 MAPK14 TMPO MAPK11 MAP2K3	8.45e-06	192	201	10	2785_DN
Drug	K00039	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	8.46e-06	32	201	5	CID009549277
Drug	Securinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A	CYLC1 LZTR1 NPHP4 ARHGEF16 F8 KAT5 BLZF1 TXNIP AKAP10 MAP2K6	9.68e-06	195	201	10	3470_DN
Drug	SB 239063	AKR1B1 MAPK14 MAPK3 MAPK11	9.87e-06	16	201	4	CID000005166
Drug	TAPI-1	ERBB2 ERBB4 AKR1B1 GP1BA EGFR MAPK3	1.10e-05	57	201	6	CID009827273
Drug	myo-inositol	ERBB2 ERBB4 PLCXD2 ADRA1D SAG FLRT2 AKR1B1 CACNA1F CACNB1 CACNB4 KAT5 RGS3 MAPK14 EGFR ARHGEF1 MAPK3 MAPK11 MAP2K3 MAP2K6 ATP2B3 SORD	1.10e-05	811	201	21	CID000000892
Drug	Propantheline bromide [50-34-0]; Down 200; 9uM; HL60; HT_HG-U133A	LZTR1 NPHP4 FLRT2 BAHCC1 CACNB4 DDX31 ARFGEF2 DNAJB4 BLZF1 CCDC88A	1.11e-05	198	201	10	3013_DN
Drug	lapatinib	ERBB2 ERBB4 MAPK14 EGFR RIMS1 MAPK3 MAPK11	1.12e-05	86	201	7	CID000208908
Drug	GF109203X	ERBB4 KCNH7 PLCXD2 KAT5 RGS3 MAPK14 EGFR ARHGEF1 TMPO MAPK3 MAPK11 MAP2K3 MAP2K6	1.15e-05	341	201	13	CID000002396
Drug	Josamycin [16846-24-5]; Up 200; 4.8uM; MCF7; HT_HG-U133A	ERBB4 ITIH2 FHL1 BAHCC1 CACNA1F BLZF1 ARHGEF1 ZNF350 MAPK11 MASP2	1.16e-05	199	201	10	1534_UP
Drug	AC1L2R3A	AKR1B1 GPD2 B4GALNT2 SORD	1.28e-05	17	201	4	CID000101562
Drug	pyridinyl imidazole	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	1.54e-05	36	201	5	CID000005171
Drug	chelerythrine	PDE2A TRPM7 ADRA1D AKR1B1 SLC12A6 MAPK14 SLC9A5 EGFR MAPK3 MAPK11 SLC12A7 MAP2K3 MAP2K6	1.86e-05	357	201	13	CID000002703
Drug	vanadyl	PDE2A ERBB4 AKR1B1 DNAH10 MAPK14 EGFR MAPK3 MAPK11 MAP2K3 MAP2K6 SORD DNAH11	1.96e-05	307	201	12	CID000061671
Drug	Cp-38	MAPK14 MAPK11 MAP2K6	2.31e-05	7	201	3	CID006918286
Drug	Go6983	MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	2.61e-05	40	201	5	CID000003499
Drug	I50 - 9	ERBB4 EGFR MAPK3	3.67e-05	8	201	3	CID000083651
Drug	Withaferin A [5119-48-2]; Down 200; 1uM; PC3; HT_HG-U133A	INPP5B FARP2 KMT2A TNPO2 E2F8 TXNIP MAPK14 TMPO MAP2K6	4.28e-05	186	201	9	3819_DN
Drug	AC1L1KS5	TRPM7 PLCXD2 CACNA1F CACNB1 CACNB4 KAT5 MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6 ATP2B3	4.46e-05	334	201	12	CID000005631
Drug	AC1L1JGQ	MAPK14 EGFR MAPK3 MAPK11 MAP2K3 MAP2K6	4.57e-05	73	201	6	CID000005034
Drug	PD158780	ERBB2 ERBB4 EGFR MAP2K3 MAP2K6	5.21e-05	46	201	5	CID000004707
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A	PDGFA FRMD4B KMT2A CAMSAP1 FHL1 TXNIP TMPO NUP188 MASP2	5.26e-05	191	201	9	3926_DN
Drug	Nimodipine	CACNA1F CACNB1 CACNB4	5.48e-05	9	201	3	DB00393
Drug	Chlorambucil [305-03-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A	CYLC1 IL1RL2 ITIH2 ADRA1D GLI2 CAMSAP1 DDX60 TMPO MAPK11	6.18e-05	195	201	9	3869_UP
Drug	Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; HL60; HT_HG-U133A	ERBB2 IQSEC1 FHL1 ARFGEF2 BLZF1 RGS3 TNFRSF11B ARHGEF1 SLC12A7	6.18e-05	195	201	9	2333_UP
Drug	Sulfadiazine [68-35-9]; Up 200; 16uM; PC3; HT_HG-U133A	SETD1A FHL1 DNAJB4 KDM4D CCDC88A MAPK14 MAP3K13 MAPK11 MAP2K6	6.42e-05	196	201	9	1810_UP
Drug	Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A	INPP5B FANCA ADRA1D CHST10 BLZF1 TXNIP ARHGEF1 TMPO ZNF350	6.42e-05	196	201	9	1708_UP
Drug	tyrphostin RG13022	ERBB4 KAT5 EGFR MAPK3	6.45e-05	25	201	4	CID000005060
Drug	Quinazolines	ERBB2 MAPK14 EGFR MAPK3	6.45e-05	25	201	4	ctd:D011799
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	CHST10 DNAJB4 E2F8 MAPK14 TMPO ZNF350 MAP2K3 MAP2K6 ZNF292	6.68e-05	197	201	9	1224_DN
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; HL60; HT_HG-U133A	CYLC1 SVIL BLZF1 MAPK14 MACF1 AKAP10 ZNF350 MAP2K3 MAP2K6	6.95e-05	198	201	9	2345_DN
Drug	Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A	ABR FHL1 MNT KAT5 DNAJB4 BLZF1 MAP2K3 MAP2K6 SNX1	6.95e-05	198	201	9	6211_DN
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	LZTR1 ADRA1D SVIL FHL1 KAT5 DNAJB4 HDAC7 SLC9A5 MAP2K3	6.95e-05	198	201	9	6812_DN
Drug	Solasodine [126-17-0]; Up 200; 9.6uM; PC3; HT_HG-U133A	FRMD4B SAG FLRT2 TNPO2 CSF2RB RIMS1 MAP3K13 NUP188 MAPK11	6.95e-05	198	201	9	3749_UP
Drug	PF-01378883-00 [351320-41-7]; Down 200; 10uM; PC3; HT_HG-U133A	PDE2A INPP5B APC2 ATP9B BMPR1B CAMSAP1 TNFRSF11B EGFR RIMS1	7.22e-05	199	201	9	6368_DN
Drug	N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide	ERBB2 EGFR	7.76e-05	2	201	2	ctd:C570404
Drug	Lapatinib	ERBB2 EGFR	7.76e-05	2	201	2	DB01259
Drug	BPIQ-I	ERBB4 EGFR MAPK3	7.77e-05	10	201	3	CID000002427
Drug	GU-5	CDR2 GFPT1 AKR1B1	7.77e-05	10	201	3	CID000448682
Drug	AC1NOLIT	MAPK14 MAPK3 MAPK11	7.77e-05	10	201	3	CID005090286
Drug	6-(methylamino)pyrido(3,4-d)pyrimidine	ERBB2 ERBB4 EGFR	7.77e-05	10	201	3	ctd:C107875
Drug	CP-654577	ERBB2 MAPK14 MAPK3	7.77e-05	10	201	3	ctd:C477330
Drug	SU11274	AKR1B1 MAPK14 EGFR MAPK3	8.82e-05	27	201	4	CID009549297
Drug	AC1L45LU	ERBB2 CENPC FANCD2 KMT2A ABCB5 MAPK14 EGFR MAPK3 MAPK11	9.06e-05	205	201	9	CID000151069
Drug	Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	KMT2A TNPO2 DNAJB4 BLZF1 TXNIP KLF10 ZNF350 ZNF292	9.11e-05	160	201	8	5275_UP
Drug	EGFR inhibitor	ERBB2 ERBB4 MAPK14 EGFR MAPK3 MAPK11 MAP2K3	9.65e-05	120	201	7	CID009549299
Drug	afimoxifene	ERBB2 SVIL EXOSC2 TATDN3 MAPK14 KLF10 EGFR TMPO MAPK3 MAPK11 MAP2K3 MAP2K6 RPL6 PRODH	9.74e-05	479	201	14	ctd:C016601
Drug	JS-1	ERBB4 AKR1B1 EGFR SORD	1.02e-04	28	201	4	CID000129920
Drug	Mibefradil	CACNA1F CACNB1 CACNB4	1.06e-04	11	201	3	DB01388
Drug	BE-23372M	ERBB2 ERBB4 EGFR	1.06e-04	11	201	3	CID005311105
Drug	nemorosone	MAPK14 MAPK3 MAPK11	1.06e-04	11	201	3	CID000637105
Drug	tyrphostin 25	ERBB4 MAPK14 EGFR MAPK3 MAPK11 MAP2K3 MAP2K6	1.07e-04	122	201	7	CID000002061
Drug	sulindac sulfone	ERBB2 PDE2A AKR1B1 EGFR MAPK3	1.14e-04	54	201	5	ctd:C025463
Drug	cariporide	SACS MAPK14 SLC9A5 ARHGEF1 MAPK3 MAPK11	1.15e-04	86	201	6	CID000151172
Drug	C11102	GPD2 MAPK14 MAPK3 MAPK11 MAP2K3 MAP2K6	1.15e-04	86	201	6	CID000443069
Drug	PD 169316	MAPK14 EGFR MAPK3 MAPK11	1.18e-04	29	201	4	ctd:C408604
Drug	2,4,4'-trichlorobiphenyl	NUSAP1 ABR RAPH1 FANCA FANCD2 IGSF10 LRRC37A KIF15 SACS GLI2 DMD IL17RB CACNA1F TICRR SMCHD1 RFC3 USH1C E2F8 VSTM2L CKAP2L AKAP10 RIMS1 MAPK3 PRR11 ATP2B3 CD96 MASP2	1.25e-04	1411	201	27	ctd:C081766
Drug	glutamate	GLS2 TRPM7 PLCXD2 GFPT1 FANCD2 ADRA1D SYT4 GPD2 CACNA1F CACNB1 CACNB4 ABCB5 PDHX TNFRSF11B MAPK14 IFT122 RIMS1 MAPK3 MAPK11 PRODH SORD	1.29e-04	962	201	21	CID000000611
Drug	L001226	MAPK14 BHLHE23 MAPK3 MAPK11	1.35e-04	30	201	4	CID004373102
Drug	N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide	ERBB2 EGFR MAPK3	1.41e-04	12	201	3	ctd:C562238
Drug	Canertinib	ERBB2 EGFR MAPK3	1.41e-04	12	201	3	ctd:C420268
Disease	Eye Abnormalities	FREM1 BMPR1A BMPR1B IFT122	4.28e-06	17	197	4	C0015393
Disease	Malignant Head and Neck Neoplasm	ERBB2 FANCA FANCD2 EGFR MAPK3	1.11e-05	44	197	5	C0278996
Disease	Colorectal Carcinoma	NUSAP1 TRPM7 APC2 ABCA10 NDST3 BMPR1A SACS DMD CACNB1 ABCB5 EGFR ARHGEF1 B4GALNT2 SNRNP200 RPL6 ZNF292	2.18e-05	702	197	16	C0009402
Disease	spermatogenic failure (implicated_via_orthology)	DNAH10 CCDC34	4.43e-05	2	197	2	DOID:0111910 (implicated_via_orthology)
Disease	cardiovascular disease biomarker measurement, internal carotid intimal medial thickness	RAPH1 ABI2	4.43e-05	2	197	2	EFO_0005053, EFO_0005278
Disease	cervical cancer (is_implicated_in)	FANCA KMT2A MAP2K3 MAP2K6	4.61e-05	30	197	4	DOID:4362 (is_implicated_in)
Disease	gallbladder neoplasm	ERBB2 ERBB4 EGFR	4.65e-05	11	197	3	C0016978
Disease	Malignant neoplasm of gallbladder	ERBB2 ERBB4 EGFR	4.65e-05	11	197	3	C0153452
Disease	median neuropathy (biomarker_via_orthology)	ERBB2 ERBB4 EGFR	1.01e-04	14	197	3	DOID:571 (biomarker_via_orthology)
Disease	diabetic neuropathy (implicated_via_orthology)	AKR1B1 MAPK14 SORD	1.01e-04	14	197	3	DOID:9743 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	ERBB2 PDE2A ERBB4 PDGFA RAPH1 APC2 LRRC37A2 ZC3H11A TAS2R13 LRRC37A DMD UBD ARFGEF2 HDAC7 EGFR MACF1 MAP3K13 VPS13B PRODH	1.15e-04	1074	197	19	C0006142
Disease	serine palmitoyltransferase 1 measurement	RAPH1 ABI2	1.32e-04	3	197	2	EFO_0803055
Disease	Gastric Adenocarcinoma	TRPM7 BMPR1A BMPR1B MAPK14	2.32e-04	45	197	4	C0278701
Disease	laryngeal squamous cell carcinoma (is_marker_for)	ERBB2 ERBB4 EGFR	2.62e-04	19	197	3	DOID:2876 (is_marker_for)
Disease	levulinate 4-oxovalerate measurement	GTPBP4 ADRA1D	2.64e-04	4	197	2	EFO_0021024
Disease	complex cortical dysplasia with other brain malformations (is_implicated_in)	APC2 CAMSAP1	2.64e-04	4	197	2	DOID:0090131 (is_implicated_in)
Disease	lung adenocarcinoma (is_implicated_in)	ERBB2 ERBB4 IQSEC1 EGFR	3.23e-04	49	197	4	DOID:3910 (is_implicated_in)
Disease	Congenital absence of kidneys syndrome	FREM1 GREB1L	4.38e-04	5	197	2	C1609433
Disease	Cetuximab response	ERBB2 EGFR	4.38e-04	5	197	2	cv:CN077967
Disease	Panitumumab response	ERBB2 EGFR	4.38e-04	5	197	2	cv:CN077999
Disease	Disorder of eye	NPHP4 FREM1 SAG CACNA1F USH1C RIMS1 SNRNP200	5.81e-04	212	197	7	C0015397
Disease	restrictive cardiomyopathy (is_implicated_in)	MAP2K3 MAP2K6	6.54e-04	6	197	2	DOID:397 (is_implicated_in)
Disease	Streptococcal pneumonia	MAPK3 MASP2	6.54e-04	6	197	2	C0155862
Disease	GLIOMA SUSCEPTIBILITY 1	ERBB2 LZTR1	6.54e-04	6	197	2	C2750850
Disease	unipolar depression, depressive symptom measurement	KMT2A ARFGEF2 ZKSCAN2	6.80e-04	26	197	3	EFO_0003761, EFO_0007006
Disease	Acute monocytic leukemia	FANCA FANCD2 KMT2A	6.80e-04	26	197	3	C0023465
Disease	cerebral white matter volume change measurement, age at assessment	FRMD4B FREM1 KMT2A	8.49e-04	28	197	3	EFO_0008007, EFO_0021499
Disease	HWESASXX measurement	CACNB4 CNMD	9.11e-04	7	197	2	EFO_0021147
Disease	Miller Dieker syndrome	FANCA FANCD2 MNT	9.42e-04	29	197	3	C0265219
Disease	urate measurement, bone density	CDR2 ERBB4 FREM1 FANCA BMPR1A SPATA17 GLI2 ABCB5 PPL CSF2RB ANKRD11 DNAH11	9.87e-04	619	197	12	EFO_0003923, EFO_0004531
Disease	Developmental Disabilities	SETD1A WDFY4 MAPK3	1.04e-03	30	197	3	C0008073
Disease	Breast Carcinoma	ERBB2 PDE2A ERBB4 PDGFA APC2 LRRC37A2 ZC3H11A LRRC37A UBD EGFR MAP3K13	1.04e-03	538	197	11	C0678222
Disease	Cardiomyopathies, Primary	DMD MAPK14 MAPK3 MAPK11	1.19e-03	69	197	4	C0033141
Disease	Myocardial Diseases, Secondary	DMD MAPK14 MAPK3 MAPK11	1.19e-03	69	197	4	C0036529
Disease	susceptibility to mononucleosis measurement	ADRA1D SYT4 DMD HDAC7	1.19e-03	69	197	4	EFO_0008403
Disease	Abnormality of the skeletal system	APC2 ZNF292	1.21e-03	8	197	2	C4021790
Disease	Unilateral agenesis of kidney	FREM1 GREB1L	1.21e-03	8	197	2	C0266294
Disease	head and neck squamous cell carcinoma (is_marker_for)	ERBB2 ERBB4	1.21e-03	8	197	2	DOID:5520 (is_marker_for)
Disease	intestinal cancer (implicated_via_orthology)	ERBB2 ERBB4 EGFR	1.26e-03	32	197	3	DOID:10155 (implicated_via_orthology)
Disease	Head and Neck Neoplasms	ERBB2 EGFR MAPK3	1.38e-03	33	197	3	C0018671
Disease	breast cancer (is_marker_for)	PDGFA FANCD2 TUT4 KAT5 EGFR MAP2K3	1.57e-03	185	197	6	DOID:1612 (is_marker_for)
Disease	hip bone mineral density	RAPH1 KIF15 PDHX TNFRSF11B DNAH11	1.60e-03	126	197	5	EFO_0007702
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	DMD CACNA1F CAPN11	1.78e-03	36	197	3	DOID:11723 (implicated_via_orthology)
Disease	Abnormality of nervous system morphology	APC2 ZNF292	1.93e-03	10	197	2	C4022810
Disease	Head and Neck Carcinoma	ERBB2 EGFR	1.93e-03	10	197	2	C3887461
Disease	temporomandibular joint disorder	DMD BAHCC1	1.93e-03	10	197	2	EFO_0005279
Disease	Fanconi anemia (is_implicated_in)	FANCA FANCD2	1.93e-03	10	197	2	DOID:13636 (is_implicated_in)
Disease	cataract (implicated_via_orthology)	AKR1B1 VPS13B SORD	2.08e-03	38	197	3	DOID:83 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of breast	ERBB2 ERBB4 MAP3K13	2.59e-03	41	197	3	C0496956
Disease	Breast adenocarcinoma	ERBB2 ERBB4 MAP3K13	2.59e-03	41	197	3	C0858252
Disease	Colorectal Neoplasms	NUSAP1 TRPM7 APC2 ABCA10 ABCB5 EGFR ZNF292	2.69e-03	277	197	7	C0009404
Disease	Night blindness, congenital stationary, type 1	SAG CACNA1F	2.80e-03	12	197	2	C3501847
Disease	Night Blindness, Congenital Stationary, Type 1A	SAG CACNA1F	2.80e-03	12	197	2	C3495587
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	SAG CACNA1F	2.80e-03	12	197	2	C1864877
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	SAG CACNA1F	2.80e-03	12	197	2	C1850362
Disease	X-Linked Csnb	SAG CACNA1F	2.80e-03	12	197	2	C3711543
Disease	Papilloma	ERBB2 EGFR	2.80e-03	12	197	2	C0030354
Disease	Papillomatosis	ERBB2 EGFR	2.80e-03	12	197	2	C0205875
Disease	Papilloma, Squamous Cell	ERBB2 EGFR	2.80e-03	12	197	2	C0205874
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	SAG CACNA1F	2.80e-03	12	197	2	C1848172
Disease	mean corpuscular hemoglobin concentration	GLS2 LRRC37A2 MRPL30 FRMD4B PIBF1 TICRR ARFGEF2 FAM219B HDAC7 E2F8 EGFR MACF1 SLC12A7 MAP2K3 RPL6 VPS13B	3.17e-03	1105	197	16	EFO_0004528
Disease	schizophrenia (is_marker_for)	TNFRSF11B EGFR MAPK3	3.17e-03	44	197	3	DOID:5419 (is_marker_for)
Disease	juvenile polyposis syndrome (implicated_via_orthology)	BMPR1A BMPR1B	3.30e-03	13	197	2	DOID:0050787 (implicated_via_orthology)
Disease	Cone-rod synaptic disorder, congenital nonprogressive	SAG CACNA1F	3.30e-03	13	197	2	C4041558
Disease	Neurodevelopmental Disorders	KMT2A ANKRD11 RIMS1 ZNF292	3.54e-03	93	197	4	C1535926
Disease	mean fractional anisotropy measurement	PDGFA EGFR ANKRD11 TMEM131	3.82e-03	95	197	4	EFO_0008399
Disease	Neoplasm of lung	ERBB2 EGFR	3.83e-03	14	197	2	cv:C0024121
Disease	Fanconi anemia	FANCA FANCD2	3.83e-03	14	197	2	cv:C0015625
Disease	Lung cancer	ERBB2 EGFR	3.83e-03	14	197	2	cv:C0242379
Disease	LUNG CANCER	ERBB2 EGFR	3.83e-03	14	197	2	211980
Disease	unipolar depression, anxiety	ZKSCAN2 CCDC88A	3.83e-03	14	197	2	EFO_0003761, EFO_0005230
Disease	Cardiomyopathy, Dilated	DMD EGFR TMPO	4.06e-03	48	197	3	C0007193
Disease	Cardiomyopathy, Familial Idiopathic	DMD EGFR TMPO	4.56e-03	50	197	3	C1449563
Disease	omega-3 polyunsaturated fatty acid measurement, diet measurement	ADRA1D CD96	5.00e-03	16	197	2	EFO_0008111, EFO_0010119
Disease	Cardiovascular Abnormalities	APC2 ZNF292	5.00e-03	16	197	2	C0243050
Disease	Synostotic Posterior Plagiocephaly	FREM1 IFT122	5.00e-03	16	197	2	C1833340
Disease	Craniosynostosis, Type 1	FREM1 IFT122	5.00e-03	16	197	2	C4551902
Disease	Acrocephaly	FREM1 IFT122	5.00e-03	16	197	2	C0030044
Disease	gliosarcoma	LZTR1 EGFR	5.00e-03	16	197	2	C0206726
Disease	Trigonocephaly	FREM1 IFT122	5.00e-03	16	197	2	C0265535
Disease	Scaphycephaly	FREM1 IFT122	5.00e-03	16	197	2	C0265534
Disease	Synostotic Anterior Plagiocephaly	FREM1 IFT122	5.00e-03	16	197	2	C2931150
Disease	Metopic synostosis	FREM1 IFT122	5.00e-03	16	197	2	C1860819
Disease	Brachycephaly	FREM1 IFT122	5.65e-03	17	197	2	C0221356
Disease	Night blindness, congenital stationary	SAG CACNA1F	5.65e-03	17	197	2	C0339535
Disease	Small cell carcinoma of lung	KMT2A ZDBF2 EGFR	5.66e-03	54	197	3	C0149925
Disease	body fat percentage	GFPT1 FANCA SPATA17 SYT4 DNAH10 CMTM4 SMCHD1 MACF1 MAP2K3	5.74e-03	488	197	9	EFO_0007800
Disease	leukemia	FANCA FANCD2 KMT2A	5.96e-03	55	197	3	C0023418
Disease	nephrotic syndrome (is_marker_for)	GP1BA TNFRSF11B	6.32e-03	18	197	2	DOID:1184 (is_marker_for)
Disease	Bone marrow hypocellularity	FANCA FANCD2	6.32e-03	18	197	2	C1855710

Protein segments in the cluster

Peptide	Gene	Start	Entry
SIKVRHIGLIPVKSS	USH1C	161	Q9Y6N9
KLRTVHNIPVTSNKD	ABR	481	Q12979
RSPHTQVLKSKLEEV	CCDC185	236	Q8N715
LAARNVLVKSPNHVK	ERBB2	846	P04626
ARNVLVKSPNHVKIT	ERBB4	846	Q15303
SVAHRVAQLKPKVKS	BAHCC1	1571	Q9P281
EAPTVTLHNKKALVS	BPIFB3	341	P59826
TLHSLPKSQVKRQEV	ARHGEF1	406	Q92888
HTNRKLTLEPKITVN	CFAP61	651	Q8NHU2
TIAPKKASHRILSDT	ANKRD11	396	Q6UB99
AKRSVLNNPSKHIII	CACNB1	276	Q02641
ITSLIKQHIPDAKLT	ABCA10	636	Q8WWZ4
NLVTIATKTFLRPHK	B4GALNT2	321	Q8NHY0
VKSIKASISVHSPQK	AKAP10	41	O43572
RKTNSLPLHSVKSIK	ABCB5	641	Q2M3G0
HSPSVRKLSKIATLL	BHLHE23	131	Q8NDY6
VTRAPSIQAKLQKHR	FAM219B	61	Q5XKK7
LTLSKTQRKTPTVIH	GTPBP4	21	Q9BZE4
IQAAAVSPKFVRLKH	ARFGEF2	221	Q9Y6D5
PKSHELRSKVVSLQL	ARFGEF2	396	Q9Y6D5
KSLAVASKAKTPARH	ARHGEF16	91	Q5VV41
VSPLHNAEVTLIRKK	DNAH11	1236	Q96DT5
KSSVRLLIRKVQHAP	SAG	171	P10523
AISHRIKTGKASIPL	DMD	1766	P11532
RLPTKNDKLVFVHST	CAPN11	191	Q9UMQ6
LASKSVNVKPLVTHR	SORD	311	Q00796
HNPASRLTALRVKKT	BMPR1B	476	O00238
LKDAKTVLHQKSSRP	CAMSAP1	346	Q5T5Y3
IVHVKVSSPKVLQRL	CACNB4	331	O00305
KLKEFSIVRNSLSHP	FLRT2	231	O43155
VLARSSPTDKHTLVK	ATP2B3	761	Q16720
KNTSRTHKIIAPANL	ABI2	116	Q9NYB9
DPRIKAIAAKHNKTT	AKR1B1	231	P15121
AKIQRTHVSTIRKLV	CFAP91	331	Q7Z4T9
HQKPRTLSKSVQTIS	CCDC27	86	Q2M243
NPHSPLIRVTKSSKL	NDST3	196	O95803
KATQKLPVSRHTLKH	RAPH1	116	Q70E73
TQTSPARKRITHAKV	RGS3	121	P49796
KHKTVAVASAQRSPR	CACNA1F	56	O60840
PKSSHSQERRKILSL	OR2A12	261	Q8NGT7
AVKKLSRPFQSLIHA	MAPK11	51	Q15759
AVKTHNLKAGPSRTV	GPD2	451	P43304
LNIKASTFPVHRQKL	IFT122	576	Q9HBG6
IVHQFTKVSKLPTLR	LZTR1	796	Q8N653
IHAETLKIITTPTKA	KIF15	651	Q9NS87
KARVTNTKTSKPIVH	LRRC37A2	1286	A6NM11
KARVTNTKTSKPIVH	LRRC37A	1286	A6NMS7
VKAVRILVPKAAITH	BLZF1	76	Q9H2G9
TAQASLKTKPIHTII	MGA	1026	Q8IWI9
KAHVSFKPTVAQQRI	ITIH2	246	P19823
KTIIAPKVKDRTHNV	KCNH7	356	Q9NS40
AVKKLSRPFQSIIHA	MAPK14	51	Q16539
PKVRKSVSSRIHEAV	ATP9B	531	O43861
RPKLQHSTSILRKQA	IQSEC1	81	Q6DN90
HQKKQTRASVVIPVT	IL17RB	226	Q9NRM6
QPNHRSTKRKVEVVS	KAT5	141	Q92993
ISTSVHKKQSFVLSP	DYNC2I1	771	Q8WVS4
SVLKHSLLSFKQPRV	DDX60	1391	Q8IY21
LKRQTRSSPVLQHKI	CCDC88A	1646	Q3V6T2
TSKVRPATEHFKTAL	PCSK5	1731	Q92824
VTLTNHKKSVRAVVL	PLRG1	366	O43660
VIAKRLTESKSTVPH	PDHX	286	O00330
HVSKRARLQSPATKV	PPL	821	O60437
TKVSHKFTIRGLPSN	PDE2A	896	O00408
PLKSQITVTRHDKRK	CYLC1	51	P35663
PKNTEVLRTTLKHSN	FAM214A	776	Q32MH5
SFPTHKRKAKVSIIS	FREM1	1961	Q5H8C1
VSVKQLFSTLPVRHK	PMS2P5	51	A8MQ11
FLRHKVALISPTVLK	KDM4D	241	Q6B0I6
KKANSLARLAHTLPV	MNT	41	Q99583
VNPVAIHKRSKVKTE	GLI2	366	P10070
RIPIHKFTTALKATG	GLS2	86	Q9UI32
EKVKRSVSPLLSTHV	MSANTD3	91	Q96H12
SFIQIRSVAKKHPKT	F8	386	P00451
TRVAIKKISPFEHQT	MAPK3	66	P27361
AKTPVTLKQRRVEHN	TMPO	206	P42167
ISSPQKSTKHVREQI	LRRC63	86	Q05C16
KRTAITTPNFKKLHE	NUSAP1	176	Q9BXS6
SLTKTPARKSAHVTV	NUSAP1	296	Q9BXS6
LKQHVTVVPSKLRLV	DDX31	481	Q9H8H2
VISHNPETKKTRVKL	RPL8	136	P62917
LVQVSPSLVKRQKTH	EXOSC2	171	Q13868
VSLKTVLQHIEATPK	GREB1L	1646	Q9C091
RSPDHVLKNTISVKA	MACF1	861	Q9UPN3
SSAVPTKHAKVLFRA	NPHP4	1096	O75161
RLTRPISKKSFLQHV	PTPRQ	2011	Q9UMZ3
SILPAHTKTKSVTRQ	RIMS1	1066	Q86UR5
KSPNVLVTHTDAVKI	MAP3K13	281	O43283
SKIPVSKIIQSRIHQ	IL1RL2	61	Q9HB29
KRTVSRVSHPVSKAR	FHL1	231	Q13642
PRKAAAKSEHITKNI	FRMD4B	876	Q9Y2L6
KPISIVKSRLHQNCS	SLC37A2	41	Q8TED4
RNVLVKTPQHVKITD	EGFR	841	P00533
TPARTLLAKQHKTQR	APC2	1911	O95996
LLAKQHKTQRSPVRI	APC2	1916	O95996
TISSSSKEVLRKHLP	DNAJB4	321	Q9UDY4
TVVKLHESSRHNAKP	IGSF10	1501	Q6WRI0
VSVQPRRAEKHIKSS	CSF2RB	321	P32927
FTRHPSLIKLVKSIE	E2F8	391	A0AVK6
KRPVISQPHKSSSLV	CCDC34	341	Q96HJ3
HKNKKDPRSLTVTLT	PRMT3	506	O60678
KRKSESSPIVRHAAT	CENPC	271	Q03188
SHRKPLKRSSSETIL	CDR2	301	Q01850
IIKDNSLVLTPSHIK	CDK7	101	P50613
SARPSAKNSIHIKEI	CEP126	471	Q9P2H0
TSHPVLLTVEQRKKL	FANCA	131	O15360
VKIPTQRKPISSIHA	CMYA5	2126	Q8N3K9
HNPASRLTALRIKKT	BMPR1A	506	P36894
SFLNHLTRKKPATRI	C20orf144	31	Q9BQM9
RATRTVVKFPTKAHT	GP1BA	306	P07359
KTLPHRIETKSNTVT	MASP2	261	O00187
KLQLTHKRRPSLTVA	HUS1B	101	Q8NHY5
KALPLKLINRTHATV	CEP192	1516	Q8TEP8
SKQVISTLPIFHKNV	INPP5B	916	P32019
KLPKAQATSVIRHTA	KLF10	146	Q13118
TSSHRTVPNIIKRSK	KMT2A	3276	Q03164
QVFSITEHSPLSKRK	CCDC168	4786	Q8NDH2
LNHKISPKASVSLIR	CCDC168	5721	Q8NDH2
EVALTKLTKSVSAPH	FAM135B	761	Q49AJ0
LKTHVQVIKRSAKPS	HDAC7	381	Q8WUI4
KTHTSVRALTADLPK	FARP2	371	O94887
SKTHLRVIKVAPLQN	CCDC198	6	Q9NVL8
SALHEQTKLPIVRKV	DNAH10	291	Q8IVF4
FARKHESPLLVTKSQ	RUBCN	191	Q92622
VKHPRLLTFASQLKA	SLC12A6	771	Q9UHW9
VKHPRLLSFTSQLKA	SLC12A7	706	Q9Y666
QITSLLPTHKDALRK	SACS	891	Q9NZJ4
SSVVSEPHVIRVQKK	PKD1L1	576	Q8TDX9
KKSLSIRAPQVHSEV	C18orf63	396	Q68DL7
SVAASSHVPIQKKLR	CUL4B	106	Q13620
TPHTVTAISAKIRKK	FANCD2	851	Q9BXW9
TRLTQHVPLLKKTLE	FANCD2	1351	Q9BXW9
KLRIEHQTITTPSKK	RFC3	66	P40938
HKAVLTPAVTKVISR	OTOG	1676	Q6ZRI0
HSKLSVIHRDVKPSN	MAP2K3	181	P46734
SKLSVIHRDVKPSNV	MAP2K6	171	P52564
TKIAVHSPKISQRRT	MCM9	946	Q9NXL9
RVTKTHQLAVKLEPR	SYDE2	771	Q5VT97
TNTLTVVVLKARHLP	SYT4	301	Q9H2B2
VVVLKARHLPKSDVS	SYT4	306	Q9H2B2
DPRTKVHTNALKIVI	TAS2R13	221	Q9NYV9
KTTTTIIPKRIAHSP	REXO1	781	Q8N1G1
HRRPKVKQKDSTSLT	SPATA17	201	Q96L03
LQPHKKSSTKRLREV	ATP6V1C2	366	Q8NEY4
PVQKPTLHRSISTKV	RNF207	396	Q6ZRF8
VTTQNALKLFPKLRH	TATDN3	256	Q17R31
KTIKLLPSSHVARLQ	SMCHD1	1026	A6NHR9
TTQQVPHIEALLKRK	SMCHD1	1681	A6NHR9
LTSSVAEHKRAVRPK	SVIL	1341	O95425
QNPHKLHIVTRIKST	MRPL30	61	Q8TCC3
LTKARKLSRAPVVTH	TCAF2	581	A6NFQ2
IKNTKRTIKVPHSVD	GFPT1	646	Q06210
IDSRTKLSKHLVVPN	PRODH	321	O43272
KIVFHLSRKVTSLVP	SLC9A5	61	Q14940
SKPEVTVRLNVHKVT	UBA2	446	Q9UBT2
RVRNITKKSSHLPLG	STARD9	1051	Q9P2P6
RSTHVVLEKAKSRPL	PROB1	286	E7EW31
VHHTITNLTTPKRKR	SETD1A	1466	O15047
SISRSSKSVAKLLHP	SPATA9	81	Q9BWV2
SIVPHRKSDLSKVVV	SLC28A2	551	O43868
PTTQLRAKVSSLSHK	ADRA1D	506	P25100
ALKNLSHTPVSKFVL	CHST10	96	O43529
TVRKKSPTNLLSLNH	CMTM4	216	Q8IZR5
KSTIRPKNDVTNHVV	CKAP2L	51	Q8IYA6
TNHVVLPVKPKRSIS	CKAP2L	61	Q8IYA6
HFIRTLSKVQSSKKP	CKAP2L	281	Q8IYA6
VVRKIVPTTTKRPHS	CNMD	216	O75829
NQLLPAVKTHSEVRK	CNOT10	706	Q9H9A5
AKTRTQVHQPSLVKL	PGBD2	441	Q6P3X8
GSVVQFKIKRHTPLS	SUMO3	26	P55854
HVRSKTKVPVQDQVL	UBD	36	O15205
KLLVHLKATRNSVPV	SF3B2	486	Q13435
ASNVSHTVVLRPLKA	SSR2	86	P43308
HFPKTVTQSLKKTIR	TNFRSF11B	356	O00300
LLTKSVAETPVHKQI	TICRR	961	Q7Z2Z1
VAETPVHKQISKRLL	TICRR	966	Q7Z2Z1
SIKKTKHLRLSQPSE	ZBTB8A	206	Q96BR9
VKVRTPSRKLSEHNT	USP45	751	Q70EL2
LAAKKTHTSQIEVIP	RORC	16	P51449
LELKSVLTRVHSNKP	CD96	331	P40200
QPSRVHHRSVKVAKV	PDGFA	141	P04085
KPFSQHVRKLRASIT	RPL6	131	Q02878
AVVSKHQSPKITTSL	SNX1	51	Q13596
HVSQAILTPRVKTIA	PLCXD2	261	Q0VAA5
QDIKPRFHKSRTVTL	TNPO2	331	O14787
RHLTKRLPTKSSQKV	ZC3H11A	606	O75152
KSVKVKFTPVHNRTV	TMEM131	936	Q92545
VPTTAKRRLKQSVHL	PIBF1	566	Q8WXW3
PHVTLHVKQSSKERL	ZNF292	586	O60281
QLTHKSPIERQKSLL	WDFY4	56	Q6ZS81
LNHDVVKISPKSVRN	ZDBF2	2151	Q9HCK1
KILSKTLAALRHFTP	NUP188	1556	Q5SRE5
VRASISKAPKIIIFH	USP50	256	Q70EL3
RSTLKKALPTLSHIQ	YJU2B	156	P13994
DTKRQKPSVHSRQLV	YTHDC1	56	Q96MU7
KPSVHSRQLVSKPLS	YTHDC1	61	Q96MU7
RLHTAIKFPASQKLI	ZNF350	171	Q9GZX5
LSVHLQPITRSTLKV	SNRNP200	1186	O75643
NKPNIHKRVLTEATV	ZNF251	156	Q9BRH9
ISTSLIKQIATKVHP	VPS13B	2911	Q7Z7G8
QALHSISVAKKRVIS	WASHC4	511	Q2M389
VKEKSVHAIQVPARS	ZKSCAN2	306	Q63HK3
KIIRSSRKVVEHSNP	TASOR2	806	Q5VWN6
SFQIVSATHKKIPTI	ZNF354A	141	O60765
KIPTIERSHKNTELS	ZNF354A	151	O60765
SNISHKLRLSRVKPT	VSTM2L	121	Q96N03
SRIVVPKAAIVARHT	TXNIP	206	Q9H3M7
TTAKVPIVKFEHRRS	TUT4	1051	Q5TAX3
KVSPVAHKHLSRQKI	TBC1D10A	251	Q9BXI6
QHVTLKPNSKVLSTR	PRR11	266	Q96HE9
PRTIALAKSKSVHQD	THEGL	381	P0DJG4
RTVISLPKHKSVVVT	ZFC3H1	696	O60293
KSTVEKRNAAHVLPQ	ZNF285	216	Q96NJ3
RTSIPVHSKQAEKIS	TRPM7	1486	Q96QT4
VHSKQAEKISRRPST	TRPM7	1491	Q96QT4
HKPKSVLLQRSSSEV	ZBBX	216	A8MT70
TKSRVARKAHVATPV	ZNF518B	756	Q9C0D4